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Abstract 
 
PHENOLIC CONSTITUENTS FROM 
GARCINIA INTERMEDIA AND RELATED SPECIES 
 
by 
 
Ulyana Muñoz Acuña 
 
Adviser: Dr. Edward J. Kennelly 
 
Antioxidants from plants scavenge free radicals and prevent reactive oxygen 
species from having damaging effects in common ailments such as inflammation, 
atherosclerosis, and Alzheimer’s disease. As part of our ongoing studies of antioxidants 
from tropical edible fruits, we have studied Garcinia intermedia (Pittier) Hammel 
[synonym: Rheedia edulis (Seem.) Planch. & Triana], native to Central America. In the 
fruits the following compounds were identified: guttiferone A, guttiferone E, 
xanthochymol, fukugetin, volkensiflavone and fukugeside. A new compound was 
tentatively identified in the fruits of this species. The antioxidant activity of guttiferone A 
in the 1,1-diphenyl-2-picrylhydrazyl (DPPH) assay was IC50 = 46 µM. The 
antiproliferative effect of guttiferone A against colon cancer cells (HT-29) was IC50 = 
15.8 µM. 
A reversed-phase high-performance liquid chromatography (RP-HPLC) method 
with diode array detection (DAD) was developed and validated to quantify seven major 
phenolic compounds in eight Garcinia species from different geographic regions: G. 
mangostana, G. xanthochymus, G. spicata, G. livingstonei, G. intermedia, G. 
hombroniana, G. kola, and G. aristata. Garcina intermedia and G. mangostana had the 
highest antioxidant activities. 
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Chapter 1 
Introduction 
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Fruits and vegetables are rich in essential antioxidant nutrients, including the pro-
vitamin β-carotene, and the vitamins C and E. Additional antioxidants, such as 
polyphenols ingested through the daily diet increase the antioxidant capacity of plasma1, 
and are an important source of protective compounds against the damaging effects of free 
radicals.2 The benefits of certain non-nutritional antioxidants such as flavonoids have 
been evaluated in several epidemiological studies.3,4,5 In particular, it has been shown that 
a diet rich in fruits and vegetables significantly reduces the incidence and mortality rate 
of cardiovascular diseases.6 A high intake of fruit and vegetables has been shown to have 
protective effects against cancer.7, 8  
 Additional antioxidants, such as polyphenols present in the daily diet, increases 
the antioxidant capacity of plasma.1 Polyphenols are an important source of protective 
compounds against the damaging effects of free radicals.2 Free radicals are very reactive 
in biological systems and are involved in producing reactive oxygen species (ROS) such 
as O2•, ROO•, RO•, HO•, and NO•. ROS are naturally involved in cellular respiration, 
phagocytosis and synthesis of biologically important compounds. However, they are also 
damaging to lipids, proteins, and DNA and are formed in ailments such as cataracts, 
Alzheimer’s disease, certain inflammatory conditions, and atherosclerosis.9  
Plants in the Clusiaceae are a rich source of secondary metabolites with biological 
activities. The major classes of secondary metabolites have been isolated from these 
plants are: xanthones, coumarins and benzophenones. The Clusiaceae comprises 36 
genera and around 1600 species,10 which are mainly distributed throughout the tropics, 
although plants in a few genera are found in temperate regions.11 The presence of latex is 
a common character of this family. The Clusiaceae is comprised of three subfamilies: the 
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Kielmeyeroideae, the Hypericoideae, and the Clusioideae.11 The genus Garcinia includes 
more than 250 species of dioecious trees and shrubs with pantropical distribution, with its 
center of diversity in Southeast Asia and Madagascar. The floral characters exhibit a high 
variability in this genus, thus taxonomical issues arise when studying these plants. A 
broad concept of the genus, was supported by a recent molecular phylogenetic study, 
including a geographically, morphologically, and taxonomically comprehensive 
sampling.12 The previously segregated genera Rheedia, Ochrocarpus, Pentaphalangium 
and Tripetalum are now accepted as part of genus Garcinia (Table 1.1), although in this 
thesis, names in Rheedia are sometimes used as reported in the literature.  
Table 1.1. Classification of genera in the Clusiaceae.11 
I. Subfamily  
Kielmeyeroideae Engler 
II.         Subfamily  
Hypericoideae Engler 
III.        Subfamily 
 Clusioideae Engler 
A. Tribe Calophylleae Choisy 
Neotatea Maguire 
Marila Swartz 
Mahurea Aublet 
Kielmeyera Martius 
Caraipa Aublet 
Haploclathra Bentham 
Poeciloneuron Beddome 
Mesua L. 
Kayea Wall. 
Mammea L. 
Calophyllum L. 
 
B. Tribe Endodesmieae Engler 
Endodesmia Bentham 
Lebrunia Staner 
 
A. Tribe Vismieae Choisy 
Vismia Vand. 
Harungana Lamarck 
 
B. Tribe Hypericeae Choisy 
Hypericum L. 
Lianthus N. Robson 
Triadenum Raf. 
Thornea Breedlove & 
McClintock 
Santomasia N. Robson 
 
C. Tribe Cratoxyleae Bentham 
Cratoxylum Blume 
Eliea Cambess. 
 
A. Tribe Clusielleae (P.F.Stevens) 
Clusiella Planch. & Triana 
 
B. Tribe Clusieae Choisy 
Clusia L. 
Dystovomita D’Arcy 
Tovomita Aublet 
Chrysochlamys Poepp. 
Tovomitidium Ducke 
 
C. Tribe Garcinieae Choisy 
Garcinia L. 
Pentaphalangium Warb. 
Rheedia L.  
Tripetalum K. Schum. 
Allanblackia Oliver 
Ochrocarpus Thouars. 
D. Tribe Symphonieae Choisy 
Pentadesma Sabine 
Moronobea Aublet 
Platonia Martius 
Montrouziera Planch. & Triana 
Lorostemon Ducke 
Thysanostemon Maguire 
Symphonia L. f. 
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The antioxidant capacity of plants is mainly attributed to the phenolic 
constituents.13 Phenolic compounds are antioxidants found in plants, and can be found in 
agricultural crops such as apples, grapes, blackberries, and strawberries.14 In my research, 
the phenolic content of edible Garcinia fruits (Clusiaceae) has been studied. Products 
containing G. mangostana are commonly sold as dietary supplements in the US. This 
phytochemical investigation included eight Garcinia species from different geographical 
origins. In this study, the main objectives were; [i] a literature review of the bioactivity of 
polyisoprenylated benzophenones15, [ii] identification of new polyisoprenylated 
benzophenones isolated from Garcinia intermedia,  [iii] identification and quantification 
of polyisoprenylated benzophenones and biflavonoids in eight Garcinia species, [iv] in 
vitro investigation of the antioxidant and antiproliferative effects against colon cancer 
cells of guttiferone A. 
 5
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 2 
Polyisoprenylated Benzophenones from Clusiaceae: Potential Drugs and Lead 
Compounds 
A Review* 15 
 
 
 
 
 
 
 
 
 
 
 
 
 
*This chapter has been published previously. 
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2.1. Introduction 
Natural products of plants origin are important sources of new chemical 
compounds leading to the future discovery of new drugs. In the areas of cancer 
chemotherapies, anti-inflammatory drugs, antibacterial drugs, and antiparasitic drugs, 
there is demand for new, more effective treatments.16 Herein, we examine the bioactivity 
of the polyisoprenylated benzophenones isolated from plants of the Clusiaceae family. 
The Clusiaceae family is a rich source of secondary metabolites, including the widely 
used medicinal herb Hypericum perforatum L., commonly known as St. John’s wort, 
which has been traditionally used for its antidepressant activity.17 Four major classes of 
compounds are found in the Cluisaceae family: xanthones, coumarins, biflavonoids, and 
benzophenones. 
The polyisoprenylated benzophenones are major intermediates in the biosynthetic 
pathway of xanthones, and have been rarely reported to occur outside the Clusiaceae 
family.18 The benzophenones are non-polar phenolic compounds, with increased 
hydrophobicity as a function of the number of prenyl functional groups attached. Most 
polyprenylated benzophenones isolated from plants have the bicyclo[3.3.1]-nonane-2,4,9-
trione core structure linked to a 13,14-dihydroxy substituted phenyl ring (Fig. 1).19 This 
planar structure, with polar carbonyl and hydroxyl groups, can be simple or substituted 
by isoprene units.  
Benzophenones exhibit cytotoxic,20 antimicrobial,21,22 antiviral,23 and 
antioxidant24, 25, 26 activities. The most cited natural benzophenones in the literature are 
garcinol (1) and xanthochymol (2) (Tables 1 and 2). These compounds are cytotoxic in 
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several cancer cell lines including colon,25, 27, 28 breast,28, 29, 30 ovarian,31, 32, 33 oral, 34, 35 
and leukemia.36, 37 
Polyisoprenylated benzophenones induce apoptosis and arrest the cell-cycle in 
sub G1-phase 38; however, the mechanism of action by which benzophenones in induce 
apoptosis and exert cytotoxic effects is still under investigation.  
Several groups have independently investigated the mechanism of action of 
polyisoprenylated benzophenones.34,37,38 Although studies have shown that 
polyisoprenylated benzophenones bind to microtubules and inhibit the disassembly of 
tubulin during cell division, our findings show38 that benzophenones increase the activity 
of caspase-3, possibly inducing apoptosis.38 Benzophenone action has the same 
mechanism as that of paclitaxel, but at a lower potency. Several studies suggest that 
benzophenones increase the activity of caspase-3, inducing apoptosis.27, 37, 38 Besides 
inhibition of microtubule disassembly,34 other possible mechanisms of action against 
cancer cells have been presented: inhibition of microtubule disassembly,34 inhibition of 
histone acetyl tranferase activity,39 inhibition of protease activity,40 inhibition of kinase 
activity,36 or directly acting as prooxidant damaging DNA.41  
We are not aware of any review publications on benzophenones from natural 
sources. Thus, this work presents, to our knowledge, the first summary of 
polyisoprenylated benzophenones as secondary metabolites found mainly in Clusiaceae 
family. 
This review is based primarily on Internet research of the literature using different 
electronic databases such as MEDLINE, Science-Direct, Basic-Biosis, and Chemical 
Abstracts. The following search terms, without language restrictions, were used during 
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the research: polyisoprenylated benzophenones, garcinol, xanthochymol, Clusiaceae and 
benzophenones, Garcinia sp. and benzophenones, antioxidant activity, cytotoxicity, 
antiviral, anti-HIV, antimicrobial, and antiinflammatory properties of benzophenones. 
Additionally, an advanced search was performed to select only the articles that involve 
benzophenones isolated from natural sources. Searches were performed over the time 
period, January through May 2009. 
2.2. Chemical structure 
The core of a polyisoprenylated benzophenone is composed of a bicyclo[3.3.1]-
nonane-2,4,9-trione structure, linked to a 3,4-dihydroxybenzoyl moiety (Fig. 1).19 The 
benzoyl ring is usually hydroxylated, in position ortho and para. The 3-methyl-2-butenyl 
groups or prenyl groups are attached at carbon C-1, C-5, and C-7 of the bridged bicyclic 
structure (Fig. 1). There are examples, such as isoxanthochymol (3) or cambogin (4), 
where the isoprenyl substituting unit at C-5 undergoes cyclization. During cyclization, 
the oleofinic bond undergoes epoxidation, and subsequently forms a bond with the 
oxygen on carbon C-4, forming an additional pyran ring.  
These polyisoprenylated benzophenones commonly occur as tautomeric pairs. 
That is, the diketone easily forms hydroxyl groups that are formed at C-4 and C-1 in the 
enolized diketone.  It has been suggested that the enolic hydroxyl group in the -
hydroxy-,-unsaturated ketone plays an important role concerning bioactivity.41 Keto-
enol tautomerism has been reported for curcumin, whose structure has certain similarities 
to benzophenones.42, 43  
The position C-7 constitutes a chiral center forming stereoisomers.  Thus the 
isopentenyl substituent at C-7 is either in an equatorial or in an axial position. The 
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relative configuration of benzophenone compounds can be deduced from NOE and 
ROESY spectra and the coupling constant when analyzing these compounds by nuclear 
magnetic resonance (NMR).44  
In summary, the planar ring structure of benzophenones is highly conjugated, 
with delocalized electrons and strongly polarized carbonyl and hydroxyl groups. The UV 
spectrum shows absorption bands caused by an aromatic chromophore at 282 and at 234 
nm, due to a conjugated carbonyl group. 
2.3. Clusiaceae genera 
Most of the polyisoprenylated benzophenones included in this review were 
isolated from the genus Garcinia L. The genus Garcinia (Subfamily: Clusioideae, tribe 
Garciniae) is distributed throughout tropical regions of the world. The genus Garcinia 
comprises 200 species, and some are used for their latex and resins. The fruits are edible 
and many have medicinal uses. Benzophenones isolated from seven genera, have been 
assayed for cytotoxicity: Garcinia, Rheedia, Hypericum, Clusia, Ochrocarpus, Tovomita, 
and Vismia (Table 1). Antibacterial benzophenones have been isolated from the seven 
following genera: Garcinia, Rheedia, Hypericum, Clusia, Allanblackia, Symphonia, and 
Moronobea (Table 2). Polyisoprenylated benzophenones are rarely found outside the 
Clusiaceae family. However, structurally similar isoprenylated benzophenones with 
cytotoxic activity have been isolated from Cudrania in the Moraceae family45 as well as 
from other natural sources.46  
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2.4. Effects on Cancer Cells in vitro 
2.4.1. Cytotoxicity 
Plants are an important source of cytotoxic compounds for anticancer therapies. In 
total, twenty-six studies reported cytotoxic activity for polyisoprenylated benzophenones 
isolated from plants in the Clusiaceae family (Table 1). Most of these studies were 
performed using human leukemia (HL-60) and oral carcinoma (KB) cells. Although 
benzophenones show relatively potent cytotoxic effects, paclitaxel showed a hundredfold 
more effective cytotoxic activity than the tested benzophenones.20,34,47 Paclitaxel, a 
cytotoxic compound originally isolated from Taxus brevifolia Nutt., was used as a 
positive control in three studies, comparing effects of polyisoprenylated benzophenones 
to that of paclitaxel (Table 1).20, 34, 47 
  In a comprehensive cytotoxic study,20 both xanthochymol (2) and 
isoxanthochymol (3) were tested against three different cancer cell lines, including breast 
(MCF-7), liver (WRL-68), and colon (COLO-320-DM) cancer cells. The activities of 
paclitaxel were tested in each of the cell lines: IC50= 0.005 M (MCF-7), IC50= 0.054 M 
(WRL-68), and IC50= 0.01 M (COLO-320-DM).20 Xanthochymol (2) displayed 
IC50=0.457 M (MCF-7), IC50= 2.52 M (WRL-68), IC50= 0.62 M (COLO-320-DM).20 
The IC50 values for isoxanthochymol (3) in each of the above mentioned cell lines were: 
2.85 M (MCF-7), 15.52 M (WRL-68), and 4.85 M (COLO-320-DM).20 
Kumar et al. (2007) suggested that xanthochymol (2) is more effective than 
isoxanthochymol (3) particularly against breast cancer cells MCF-7 and liver cancer cells 
WRL-68, although it is a hundredfold less effective than paclitaxel.20  
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Xanthochymol (2) was screened for cytotoxic activity in four different studies 
(Table 1), and it was more active against breast cancer cells (MCF-7) than against the 
other tested cell lines (IC50= 0.475 M), while isoxanthochymol (3) showed highest 
activity  (IC50= 0.62 M) against colon cancer cells (COLO-320-DM).48  
Guttiferone A (5) displayed activity against A2780 human ovarian cancer cell 
lines, IC50 = 6.8 g/ml.33 The effect was a thousand times weaker than the activity of the 
control actinomycin D, IC50 = 0.003 g/ml.33 Guttiferone I (6) and J (7) showed 
inhibitory activity in KB oral carcinoma cells, with an IC50 = 4.70 g/ml and an IC50 = 5.0 
g/ml, this in comparison with the control taxotere, IC50 = 0.37 ng/ml.47 Nevertheless, 
isoprenylated benzophenones from the Clusiaceae family definitely displayed cytotoxic 
activities, although consistently lower than the positive controls, paclitaxel and 
actinomycin D. 
Xanthochymol (2) was the most cytotoxic of all the tested polyisoprenylated 
benzophenones, particularly against MCF-7 cells, (IC50= 0.475 M).20 Nemorosone (8) 
was the second most active, and had a cytotoxic activity of IC50= 1.5  0.08 g/ml 
against HEPT-1 larynx cancer cells. In leukemia cells nemorosone (8) showed activity in 
the ranges of IC50 = 2.10 g/ml to IC50 = 3.10 g/ml36 (Table 1). Vismiaguianone D (9) 
was the third most active compound reported among the studied benzophenones, 
particularly against oral carcinoma cells KB, IC50 = 2.40  0.9 g/ml.35 
Oblongifolin C (9) from Garcinia yunnanensis Hu showed activity against 
cervical HeLa-C3 cells, and apoptosis was induced after 72 h of incubation with a 
concentration of 15 M.49 Tovophenone A (11) was isolated from Tovomita 
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brevistaminea Engl., and was found to be inactive against KB cells; the effective 
concentration (EC50) was 10 g/ml.50  
2.4.2. Garcinol 
The most frequently tested polyisoprenylated compound was garcinol (1), which 
showed cytotoxic effects in five studies (Table 1). Garcinol is the trivial name of 
camboginol (1),23 as they have the same stereochemical structure.23 Camboginol (1) was 
originally isolated from G. cambogia Desr. and its stereochemistry has been identified 
and reported.51  
Garcinol (1) was included in five cytotoxicity studies, and the activity and 
inhibitory concentration (IC50) ranged from 5 to 21.4 M 37 (Table 1). Treatment with 
garcinol caused the reduction of the mitochondrial transmembrane potential, an important 
evidence of apoptotic effects.37 Furthermore, it was shown that garcinol (1) increased the 
activity of caspase-3 during apoptosis.37 In another study, the activity of caspase-3 
increased when tested at 2 and 6 hours.27 
Garcinol (1) was also tested against HL-60 leukemia cells.27, 37, 52, 53 Treatment of 
leukemia cells with garcinol (1), isoxanthochymol (3), and xanthochymol (2) was shown 
to cause apoptosis, mediated by caspase-3.37 However, no activation of caspase-8 was 
found in this study.37 In this study, the effects of garcinol (1) on the cell cycle wpould 
consist in targeting the mitochondria in the early phase of the apoptotic process. 
Furthermore, another study shows that garcinol induces apoptosis and increases caspase-
3 activity in a dose-dependent manner.43 
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To date, there is no clear evidence concerning the mechanisms through which 
garcinol and other isoprenylated compounds cause apoptosis and cytotoxic effects on 
cancer cells.  
2.4.3. Inhibiton of histone acetyl transferases  
In a systematic approach to indentify compounds from plants that have effect on 
histone acetyl transferases (HAT), it was found that garcinol (1), isolated from the fruit 
rind of Garcinia indica Choisy, was a potent inhibitor of HAT, specifically p300 and 
PCAF, IC50 = 7 M and IC50 = 5 M.39 The inhibiting effects on histone 
acetyltransferases, p300 and PCAF for garcinol (1) led to apoptosis in these HeLa cells, 
suggesting that HAT inhibition might be the possible mechanism of action through which 
polyisoprenylated benzophenones from plants exert cytotoxic effects in different 
cancerous cell lines. 
The balance between acetylation and deacetylation of histones is important during 
cell growth and differentiation. Acetylation of histones plays an important role in DNA 
and protein interaction during transcription. Notably, garcinol (1) has been shown to be a 
specific inhibitor of acetylation. The concentration range of garcinol tested was between 
1 M and 100 M.39 The HAT inhibiting activity of garcinol (1) was investigated using 
HeLa cells and recombinant HAT p300 and PCAF.39 A microarray analysis showed that 
transcription was globally repressed. Further evidence showed that garcinol (1) 
competitively inhibited the activity of both p300 and PCAF, competing with histones for 
the active site of the enzyme. Very few HAT inhibitors have been reported, thus garcinol 
(1), inhibiting HAT and transcription, is a candidate molecule to be tested for future 
cancer therapies.  
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2.4.4. Gene expression analysis 
In our own studies,25, 38 xanthochymol (2) isolated from Garcinia xanthochymus 
Hook.f. showed cytotoxic activity against colon cancer cells. The reported inhibitory 
concentration against SW-480 cells for xanthochymol (2) was IC50 = 8.3 M and for 
guttiferone E (12) it was IC50 = 7.5 M.25 Xanthochymol (2) showed significant 
cytotoxicity against cell lines HCT-116 and HT-29 derived from colon cancer tissues, 
IC50 = 10 M and IC50 = 15 M.25 In addition to xanthochymol (2) and guttiferone E (12), 
guttiferone H (13) was isolated by our group and was shown to display an IC50 = 12 M 
against SW-480 cancer cells and an IC50 = 9.0 M against HCT-116.25, 38 We found that 
caspase-3 activation occurred after 24 h.38 These findings are supported by similar results 
reported by Matsumoto et al.37 and Hong et al.42 We found no significant activation of 
caspase-8 and 9 in HCT-116 and HT-29 cells.38  
The proapoptotic effect of xanthochymol (2), guttiferone E (12), and guttiferone 
H (13) in HCT116 and HT29 cells was examined more closely by microarray analysis.38 
The effect on gene expression in HCT116 and HT29 cells was studied at IC50 
concentration for 18, 24, and 48 hours. Poly(A)-RNA was extracted from cells used in 
these experiments and used as templates to synthesize biotin-labeled cDNA to perform 
the hybridization and gene array analysis. Gene tree cluster analysis showed that array 
samples clustered into three main groups, and few genes were induced.  
Genes involved in the stress response of the endoplasmatic reticulum were up-
regulated namely: X-box binding protein 1 (XBP1); activating transcription factor 4 
(ATF4); and DNA-damage inducible transcript 3 (DDIT3/CHOP), possibly a response to 
unfolded proteins and possibly affecting the progression through the cell cycle leading to 
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cell cycle arrest.38 The cellular energy stress response gene, DNA-damage inducible 
transcript 4 (DDIT4/REDD1) was highly induced by treatment. DDIT4/REDD1 is a 
transducer that inhibits the mammalian target of rapamycin (mTOR) pathway. In 
addition, our results also indicated that the mTOR survival pathway was inhibited in 
treated cells.38 The mTOR pathway plays an important role during cellular stress 
responses, cell growth and survival and it is dysregulated by various oncogenic events. It 
was found that curcumin also affects the mTOR pathway.54  
It seems that both the polyisoprenylated benzophenones and curcumin might 
target phosphatases regulating the phosphoinositide-3 kinase/Akt/mTOR pathway and 
have cytotoxic effect in cancer cells. Curcumin was found to activate protein phosphatase 
2A (PP2A) and calyculin-A in treated cancer cells. This led to dephosphorylation and 
inhibition of Akt/PKB protein kinase B and mTOR mediators. This was followed by 
inhibition of down-stream mediators of the pathway such as glycogen synthase kinase 
(GSK-3). Consequently, expression of proteins essential for cell survival and 
proliferation of a cancer cell, such as cyclin D1, was suppressed.54 However, the specific 
phosphatases activated by curcumin need to be further investigated.54 It remains to be 
determined if histone deacetylase (HDAC) inhibitor alters the activity of Akt protein 
kinase as well, through the protein phosphatase complex (PP1).55 
2.4.5. Protease inhibition 
Guttiferone A has a planar structure with strongly polarized groups which interact 
with serine proteases.40 The X-ray crystal structure confirmed that guttiferone A (5) 
bound to the active site of serine proteases. The phenyl ring and the prenyl groups present 
in guttiferone A (5) form van der Waals interactions with the catalytic site of the enzyme: 
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the hydroxyl moieties donate or accept hydrogen from the amino acids of the protein, 
thus binding more tightly to the residus in volved in the proteolytic activity of the 
enzyme. Thus hydroxylation of the bridge carbon in the benzophenone activity tautomere 
seems to be important for the activity of benzophenones.40,56 These findings suggest that 
isoprenylated benzophenones such as garcinol (1) might bind to proteases, indicating that 
both antiviral and cytotoxic effects caused by guttiferone-type compounds take place 
through binding and inhibiting proteases.40 
2.4.6. Akt/PKB kinase inhibition 
Nemorosone (8) from Clusia rosea Jacq. was found to have antiproliferative and 
proapoptotic effects in Jurkat and K-562 human leukemia cells.36 Apoptosis was induced 
within 4 hours after treatment. Later on, an increase of sub G0/G1 cell population was 
observed, and it appears that nemorosone (8) prevents the progression G1/S transition in 
cells, as well as altering the controllers of G2/M progression. These line of evidence lead 
to conclude that Akt/PKB kinase appears to be inhibited by nemorosone (8), making this 
enzyme is another likely physiological by causing apoptosis.  
Akt/PKB is a serine/threonine protein kinase that plays a fundamental role in 
carcinogenesis. As a response to damaged DNA, Akt/PKB does not activate GSK-3. 
Further, the oncogene c-Myb was down-regulated in nemorosone-treated Jurkat and K-
562 cells.  
It was shown that nemorosone (8) disrupted the cell cycle in a dose dependent 
manner. Western blot analysis showed that cyclin D1 and E were down-regulated.36 
Moreover, the cyclin-dependant kinase 1 (Cdk1/cdc2) was down-regulated and 
dephosphorylated in cells treated with (8). According to these findings and in order to 
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define more closely which pathways are affected br nemorosone during G1/S progression 
leading to apoptosis, it will be necessary to perform further studies on the physiological 
status of inhibitors of cell cycle regulators.  
2.4.7. Prooxidant activity and DNA breakage 
Garcinielliptone (14) was tested against lines derived from breast cancer cells, 
such as MCF-7. The effect of treatment in MCF-7 cells was observed using fluorescence 
microscopy. Nuclear fragmentation were observed to occur in a dose dependent manner. 
Flow cytometry analysis showed accumulation of sub-G1 DNA of apoptotic cells. 
Further, it was shown that garcinielliptone had a prooxidant effect in the presence of 
Cu(II). Nevertheless, prooxidants such as Cu(II) might not be commonly found unbound 
in the nucleus. Garcinielliptone-generated ROS, caused the breakage of DNA and, 
subsequently cell death.28, 41  
2.4.8. SAR studies   
With respect to vismiaguinones, the contrary to what other studies have 
suggested, the number of prenylated substituents in the structure, did not affect 
cytotoxicity as significantly as other substituents did.  On the other hand, the number of 
hydroxylations, the presence of an additional phenyl group and -bonds, significantly 
increase the cytotoxicity of vismiaguinones.35 Vismiaguianone A (15) through D (9) 
isolated from Vismia guianensis (Aubl.) Choisy, were tested against oral carcinoma 
cells.35 Vismiaguianones A (15), B (16), and C (17) have displayed a lower cytotoxicity 
than that of vismiaguianones D (9) and E (18) in the KB cell line.35 The vismiaguianones 
A (15) through C (17) have three hydroxyl groups, while vismiaguianone D (9) and E 
(18) have two.35 Only vismiguianones D (9) and E (18) have an additional phenyl ring, 
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and only D (9) and E (18) were the most active compounds.35 Vismiaguianone D (9) 
showed the highest activity and had a four-ring structure, with three additional -bonds 
and an ester function, possibly leading to higher cytotoxic activity.35 Thus the number of 
hydroxy-groups and double bonds correlated with higher cytotoxic activity. All the tested 
vismiaguianones had one prenyl substituting group,35 indicating that the number of 
hydroxyl groups and double bonds in the isoprenylated benzophenone are more important 
than the number of prenyl-substituent groups, in this particular case, against KB cell 
lines.  
2.4.9. Synthetic analogues and cytotoxicity 
Synthetic benzophenones were modified and tested on P388 leukemia cells and 
on PC-6 human lung carcinoma cells. Among the synthetic benzophenone derivatives 
tested for cytotoxicity, the nitrobenzophenones showed a potent cytotoxic activity both in 
vitro and in vivo.57 Whereas the aminobenzophenones showed weak activity. Fluorouracil 
(5-FU) was used as a control.57 When functional groups were oxidized the nitroketone of 
a modified benzophenone was more active than the corresponding nitro-alcohol.57 Amide 
derivatives were only weakly active.57 Among the nitrobenzophenones, the morpholino 
derivative (19) showed higher cytotoxicity and growth inhibition (GI50= 16.8 ng/ml) 
effects in vitro against P388 leukemia cells than those obtained with the positive control 
5-FU (GI50= 55 ng/ml).57 The carbonyl and nitro moieties of the synthetic analogues were 
considered to be essential for cytotoxic activity in vitro; however, in vivo, in CDF1 mice 
inoculated with P388 cells, it was the thiomorpholino derivative which increased the life 
span (ILS) by 35%, at a dose of  2 x 206 mg/kg, although the effect was not as potent as 
5-FU (82% ILS) at 2 x 100 mg/kg. Chlorination of nitrobenzophenones, in particular the 
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morpholino benzophenones, showed the highest cytotoxic activity. Further studies of 
animals treated with this compound, however, did not show an increase in the ILS of 
P388 cells inoculated in mice.57 In conclusion, given their potent cytotoxic activity and 
low toxicity the synthetic nitrobenzophenones, are promising cytotoxic compounds.57  
2.5. Effects on Cancer cells in vivo 
In an animal study, male F344 rats were fed with garcinol (1) to to test the 
hypothesis that dietary garcinol (1) suppresses chemically induced colon 
carcinogenesis.58 Oral administration of (1) showed no toxic effect on normal animal 
growth and was well tolerated with no adverse effects reported. Further in the same study 
it was shown that the dietary administration of (1) significantly inhibited and reduced the 
frequency of the chemically induced aberrant crypt foci (ACF), induced by 
azoxymethane. These findings suggested that dietary garcinol (1) suppresses chemically 
induced colon carcinogenesis in F344 rats as shown by reduced the frequency of ACF: 72 
 15 (26% reduction, P  0.01) at a dose of 0.01% and 58  8 (40% reduction, P  0.001) 
at a dose of 0.05%.58 The results from this study58 suggested that the chemopreventive 
effects of (1) on colon tumorogenesis were possibly due to the suppression of the 
production of NO and O2-. The levels of O2- and NO were induced by 12-O-
tetradecanoylphorbol-13-acetate (TPA) treatment in differentiated human promyelocytic 
HL-60 cells and lipopolysaccharide (LPS) and interferon (IFN)--treated mouse 
macrophage RAW 264.7 cells.58 In the same study, western blot analysis showed the 
suppression of inducible nitric oxide synthase (iNOS) protein expression as well as 
cyclooxygenase-2 (COX-2) protein expression. Although the mechanism through which 
(1) reduced the expression of these proteins was not presented in the above mentioned 
 20
experiments, the role of iNOS and COX-2 in inflammation and as enhancers during 
carcinogenesis in colon tissue was discussed and further studies are investigating the 
chemopreventive potential of (1).  
2.6. Antimicrobial activity  
2.6.1. Antibacterial activity 
Antibiotic resistant bacterial strains cause severe infection worldwide. The 
majority of new potent antibiotics are derived from natural products. Polyisoprenylated 
benzophenones from plants in the Clusiaceae family have significant antimicrobial 
activities (Table 2). In particular, two studies show that polyisoprenylated benzophenones 
have potent antibacterial activity against antibiotic resistant strains.22, 59 
Five benzophenone compounds isolated from G. pupurea Roxb. and G. 
subelliptica Merr. were tested against methicillin resistant Staphylococcus aureus 
(MRSA).59 Antibacterial activities of the benzophenone derivatives garcinol (1), 
isogarcinol (20), xanthochymol (2), isoxanthochymol (3), and cycloxanthochymol (21) 
were evaluated, displaying a minimum inhibitory concentration (MIC) range from 3.13 to 
12.5 g/ml for benzophenones mentioned above (Table 2).59 Xanthochymol (2) was the 
most active with a MIC = 3.13-12.5 g/ml (Table 2). Garcinol (1) showed a MIC = 6.25 
g/ml. The antibacterial activity of garcinol (1) was nearly equal to that of the positive 
control vancomycin (MIC = 6.25 g/ml), which is commonly used against Gram-positive 
bacteria.59 In addition, garcinol (1) from G. bacana Miq. showed antimicrobial effects 
against S. aureus, MIC = 16 g/ml.60 No synergistic effect was detected for 
isoxanthochymol (3) and cycloxanthochymol (21).59 
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The antimicrobial effects of 7-epiclusianone (22), isolated from the root of 
Hypericum sampsonii Hance was tested against MRSA (SA-1199B).22 This particular 
bacterial strain overexpressed the NorA efflux protein, considered the major drug pump 
responsible for antibiotic resistance. It was shown that 7-epiclusianone (22) had a MIC = 
7.3 M. The antibacterial activity of 7-epiclusianone (22) was compared to the activity of 
norfloxacin (MIC= 100 M). These results confirm that 7-epiclusianone (22) is a potent 
antimicrobial agent.  
The antimicrobial activity of 7-epiclusianone (22) was further confirmed by 
another study, where the source of the phytochemical was obtained the peel and seed 
extracts of Rheedia brasiliensis (Mart.) Planch. & Triana (synonym: Garcinia 
brasiliensis) and was tested against Streptococcus mutans.61 In this study, 7-
epiclusianone (22) showed an MIC of 1.25-2.5 g/ml,61 and the control clorhexidine had 
an MIC = 1-2 g/ml. 
Two guttiferone-type compounds, guttiferone I (6) and isoxanthochymol (3) from 
Garcinia smeathmannii (Planch. & Triana) Oliv. were tested against Gram-negative and 
Gram-positive bacteria.21 Guttiferone I (6) showed a potent activity against Gram-
negative bacterial strains, while isoxanthochymol (3), with a cyclic ring, was the most 
active against Gram-positive strains, mainly Bacillus cereus and B. stearothermophilus. 
Guttiferone I (6) showed potent activity against B. megatorium, a Gram-positive strain 
(IC50= 0.61 g/ml). It was noted that guttiferone I (6) showed higher activity than the 
control, genthamycin (IC50= 2.44 g/ml) against all tested strains in this particular study 
(Table 2).  
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The extracts from Clusiaceae plants had a more pronounced activity against the 
tested Gram-positive bacterial strains, than against the Gram-negative bacteria. The 
extracts of Garcinia cowa Roxb. and G. pedunculata Roxb. were tested against Bacillus 
cereus, B. coagulans, B. subtilis, S. aureus and Escherichia coli.62 The chloroform extract 
of the fruit rinds of G. cowa were active against B. cereus (MIC= 15 g/ml), B. 
coagulans (MIC=25 g/ml), B. subtilis (MIC= 25 g/ml), and S. aureus (MIC= 30 
g/ml). 
In another study both chamone I (23) and nemorosone (8) isolated from the 
tropical species Clusia grandiflora Splitg. showed potent antibacterial activity against 
honey-bee pathogens. Nemorosone (8) showed an activity against Paenibacillus larvae 
(total inhibition 19.5  1.6 mm) and Paenibacillus alvei (total inhibition 2.3  9 mm). 
Chamone I (23) also had activity against the above mentioned pathogens, (total inhibition 
19.7  0.3 mm) and (total inhibition 10  0.6 mm).63 Plants generally produce secondary 
metabolites as a defense mechanism; however it is possible that plants in the Clusiaceae 
family produce isoprenylated benzophenones as pollination rewards and that pollinating 
bees use the latex with these antibacterial substances for protection against pathogens. 
Nemorosone (8) has been identified and described as one of the major constituents of the 
Cuban propolis, coming from the floral resin of Clusia rosea Jacq.64, 65  
Potent antibacterial benzophenones have been isolated from natural sources other 
than plants, most notably from fungi.46, 66, 67 Pestalone (24) was obtained from a mixed 
fermentation of a marine fungus, a marine deuteromycetes (Pestalotia sp. strain CNL-
365,) and an unidentified antibiotic resistant marine bacterium.66 Pestalone (24) showed 
potent activity against MRSA (MIC = 37 ng/ml) as well as against vancomycin-resistant 
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Enterococcus faecium (MIC = 78 ng/ml).66 Benzophenone dimer, microsphaerin D (25) 
was obtained from the anamorphic fungus Microsphaeropsis strains F2076 and F2078.67 
Microsphaerin D (25) showed activity against MRSA, IC90 = 1 M.67 Pestalachloride A, 
(26) obtained from a plant endophytic fungus, showed activity against plant pathogenic 
fungi, specifically against F. culmorum (IC50 = 0.89 M).46 
2.6.2. Antiviral activity 
Activity against the human immunodeficiency virus-1 (HIV-1) was first reported 
for the polyisoprenylated benzophenone guttiferone A (5), subsequently, new lead 
molecules for antiviral drug treatment have been isolated.68 The identification of 
guttiferone A (5) was followed by the isolation and characterization of guttiferone F (27), 
which exhibited partial cytoprotection against HIV-1 in vitro (EC50 = 23 g/ml) as well as 
cytotoxicity (IC50 = 82 g/ml). Additional polyisoprenylated benzophenones from natural 
sources such as, garciosaphenone A (28) showed anti-HIV-1 activities (IC50 < 7.8 
g/ml).69 In addition, vismiaphenone D (29) showed HIV-inhibitory activity.70 
Garciosaphenone A, a new digeranylbenzophenone from G. speciosa Wall. showed 
activity against HIV-1 reverse transcriptase, IC50 = 23.9 g/ml.69  
Since these findings in natural products research, several synthetic benzophenone 
analogues have been developed and are currently important lead molecules for future 
antiviral therapies. These analogues are drug candidates for new non-nucleotide reverse 
transcriptase inhibitors (NNRTIs) have been reported to display a broad spectrum of 
antiviral activity against HIV-1 and drug resistant mutants.71 The benzophenone analogue 
GW678248 (30) showed potent antiviral activity in vitro and thus was selected for further 
preclinical studies. 
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Several synthetic benzophenone analogues showed potent activity in vitro against 
clinically relevant drug resistant mutants of HIV-1. Effective synthetic analogues were 
obtained by comparing antiviral activity to the NNRTIs nevirapine and efavirens.  
Several drug resistant strains were included in a HeLa-CD4 MAGI screening 
assay. The nevirapine resistant strain Y181C was used to test the activity of 30. The 
results showed an IC50 = 0.7  0.5 nM for 30 and an IC50 = 10,300  4,100 nM for 
nevirapine.71 Another strain, K103N, was included in the panel. The analogue (30) 
showed an IC50 = 1.0  0.9 nM while efavirens showed an IC50 = 25  13 nM, against this 
particular strain.71  
Structure-activity studies have shown that the lead structure of 30 binds to the 
non-nucleoside binding site of the enzyme, thus forming an enzyme complex.72 The part 
of the ring structure of 30 that reached the hydrophobic pocket was ring A, while the 
modified C-ring of 30 counters the scaffold of the benzophenone structure, displaying 
hydrophilic interactions. This synthetic analogue has a p-chloro substituent in the B-ring, 
which is important for the activity in particular against the resistant mutants of the 
virus.72 The additional C-ring is attached to the benzophenone core structure through a 
linker region composed of an amide group and a secondary amine. It was found that the 
carbonyl group in the benzophenone structure is important for activity.72 In addition, the 
carbonyl group shows an intramolecular hydrogen interaction with the amide NH in the 
linker region of this analogue (30).72 The para position of the C-ring was substituted with 
a sulfonamide to increase activity.72 The hydrophobic A-ring of the benzophenone was 
modified by adding a m-CN group, which showed the most potent activity of the tested 
analogues.72 Lastly, the remaining meta position of the A-ring was substituted with a 
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chlorine group72 to give this analogue a longer half-life and a lower clearance. This 
analogue (30) was selected for further preclinical evaluation.  
Pharmacokinetic studies were performed for this benzophenone analogue in rats, 
dogs, and monkeys.72 The administration of an intravenous bolus dose of 1 mg/kg in 2 ml 
injection (0.5 mg/ml) was followed by a clearance of 11, 7 and 10 ml/min/kg for rat, dog, 
and monkey, respectively. The oral bioavailability was higher for a solution than a 
suspension 27-58% for solution and 3-20% for a suspension, respectively.73 The prodrug 
of this analogue (30) showed higher oral bioavailability and is currently undergoing 
clinical studies. This drug candidate is currently in phase 2 of clinical trials and the future 
drug is expected to provide benefit to HIV-1 infected patients with strains resistant to the 
current NNRTIs.  
2.6.3. Antiparasitic activities 
Polyisoprenylated benzophenones showed potent activities as trypanocidal and 
leishmanicidal agents (Table 2).74 75 Guttiferone A (5) was isolated from the leaves of 
Garcinia intermedia (Pittier) Hammel and showed activity against Trypanosoma cruzi. 
The flagellate protista T. cruzi is the etiologic agent of Chagas disease.74 The infectious 
form is called trypanomastigotes is and the uninfectious form is designated epimastigotes. 
Guttiferone A (5) showed higher activity against the trypomastigotes at MC100 = 50 
g/ml, than against the epimastigotes at MC100 = 60 g/ml. These results represent the 
concentration at which both the epimastigotes and trypomastigotes were terminated after 
48h. Gossypol was used as a reference compound and showed trypanosomal activity at 
MC100 = 50 g/ml. In vitro activity was found for 7-epiclusianone from Rheedia 
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gardneriana Planch. & Triana against trypomastigotes of T. cruzi (LC50 = 260 g/ml), 
although this was not confirmed in vivo.76 
As for guttiferone A (5) and F (27), both displayed activities against Leishmannia 
donovani, more potent than miltefosine, the reference compound in this study. 
Leishmanicidal activity in vitro for guttiferone A (5) and F (27) were, IC50 = 0.2 and IC50 
= 0.16 M, respectively.  This was in comparison with miltefosine, IC50 = 0.47 M. 
Given the strong leishmanicidal activity displayed by guttiferone A (5) and F (27) against 
axenic amastigotes, these compounds are regarded as lead compounds in the synthesis of 
novel potent and efficient leishmanicidal agents.  
Isogarcinol (20) and cycloxanthochymol (21) were isolated from Moronobea 
coccinea Aubl., and displayed antiplasmodial activity against Plasmodium falciparum, 
particularly against a chloroquine resistant strain, FcB1. The antiplasmodial activity 
reported for isogarcinol (20) and cycloxanthochymol (21) was IC50= 3.5 M and IC50= 
2.1 M. Chloroquine showed an IC50= 0.078 M. The tetrahydropyrane ring present in 
these compounds was reported to be responsible for activity against P. falciparum. In 
addition it has been postulated that hydroxylation on the benzoyl moiety of the 
benzophenone structure is important for the activity displayed by the tested compounds.77 
Antiplasmodial activity for guttiferone A was IC50 = 3.17 M.78  
2.7. Antioxidant activities 
The antioxidant activity of garcinol (1) was investigated in four different systems, 
using the 1,1-diphenyl-2-picrylhydrazyl (DPPH) assay, superoxide anion scavenging 
assay, hydroxyl radical scavenging assay, and the H2O2/NaOH/DMSO system.26, 41, 79 The 
latter was particularly designed to evaluate both hydrophilic and hydrophobic free radical 
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scavengers.26 It was shown that garcinol (1) has high antioxidant activity in comparison 
with ascorbic acid and -tocopherol. In addition, garcinol (1) showed significant 
chelating activity and it was noted that garcinol (1) showed high scavenging activity 
against hydroxyl radicals in comparison with -tocopherol.26 This was further 
investigated in vivo, and it was shown that garcinol (1) efficiently prevented the 
development of gastric injury and ulcer, in comparison with a positive control26 These 
findings are confirmed by ethnobotanical practice and traditional use of G. brasiliensis, 
which has been reported in Brazilian folk medicine to treat peptic ulcer.80 
Free radicals and reactive oxygen species (ROS) are involved during 
carcinogenesis, neurodegenerative diseases, and inflammatory processes. The formation 
of ROS in brain tissue and subsequent oxidative damage is involved in various 
neurodegerenative diseases. Antioxidants are suggested to have neuroprotective effects. 
The neuroprotective effect of garcinol (1) from G. indica was evaluated. It was found that 
garcinol (1) protects against neuronal injury by reducing the generation of free radicals.  
The production of ROS occurs through several intracellular pathways, which 
involve mainly the activities of cyclooxygenase (COX), lipooxygenase, and inducible 
nitric oxide synthase (iNOS). During oxidative stress, astrocytes in the central nervous 
system (CNS) produce nitric oxide. It is specifically the iNOS in astrocytes that produces 
nitric oxide, which leads to neuronal death in the CNS.24 It has been shown that garcinol 
(1), reduced the expression of iNOS in a dose dependent manner and, subsequently, the 
production of nitric oxide in astrocytes, and more importantly, the effects of garcinol (1) 
enhanced neuronal survival.24 These findings suggest that polyphenols with antioxidant 
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activity from medicinal plants protect against the formation of ROS preventing neuronal 
cell death of neurons. 
2.8. Antiinflammatory Activities  
Results from several studies81, 82 have suggested that garcinol (1) possesses anti-
inflammatory and anti-carcinogenic activities. Changes in arachidonic acid (AA) 
metabolism and increased production of nitric oxide (NO) play an important role in the 
process of inflammation. Cytosolic phospholipase A2 (cPLA2), cyclooxigenases (COX), 
lypooxigenases (LOX) and NO synthases are involved in the arachidonic acid synthesis 
and NO production.81 Therefore, modulation of the arachidonic acid metabolism or NO 
synthesis, by suppressing the enzymes that are involved in their production is an effective 
way to suppress inflammation.   
Hong et al.,81 found that garcinol (1) at 1 µM modulates arachidonic acid 
metabolism in lipopolysaccharide (LPS)-stimulated murine macrophages, mainly 
blocking the activation of cPLA2 by inhibition of protein ERK1/2 phosphorylation. In 
addition, garcinol (1) suppressed iNOS expression and NO formation by modulation of 
the JAK/SAT-1 signaling pathway. Moreover, the same study 81 showed that garcinol (1) 
added to macrophages before the LPS treatment can interact with LPS receptors in these 
cells and suppress COX-2 expression. Koeberle et al.82 has shown that garcinol (1) exerts 
antiinflammatory and anticarcinogenic activities in vitro and in vivo by interacting with 
5-lipoxygenase (5-LO) and microsomal prostaglandin E2 synthase-1 (mPGES-1), two 
enzymes that are involved in inflammation and carcinogenesis. Human 5-LO and 
mPGES-1 are also molecular targets for garcinol (1), which can be used as a template for 
development and production of new drugs with antiinflammatory properties. 
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Furthermore, Neves et al. showed that 7-epiclusianone (22) isolated from G. 
brasiliensis fruit pericarp has anti-anaphylactic properties.80 In vitro experiments, using a 
model of anaphylactic histamine release from ileum tissue, have shown that 7-
epiclusianone (22) exhibited mast cells stabilizing properties by inhibiting allergen 
evoked histamine release in a dose-dependent manner with IC50 = 3.8 ± 1.8 nM. In 
comparison, the standard anti-allergic compound azelastine used as a control showed 
IC50= 6.6±2.8 nM. It was also found that 7-epiclusianone and azelastine inhibited 
allergen induced guinea pig ileum contractions with IC50 = 2.3 ± 1.1 µM and IC50 = 3.3 ± 
1.2 µM, respectively. Results from this study suggest that 7-epiclusianone (22) can be 
used as a model for future drug development with anti-anaphylactic properties.  
It was suggested that 7-epiclusianone (22) had putative mast cell stabilizing 
properties; however the antihistamine effect ex-vivo of 7-epiclusianone (22) was not as 
potent when compared to azelastine, a histamine H1 receptor antagonist. The inhibitory 
concentration was IC50 = 3.7  0.1 M for 7-epiclusianone (22), and IC50 = 6.3  0.2 nM 
for azelastine.80 Thus the pharmacological effect of 7-epiclusianone (22) when tested in 
ex vivo guinea pig ileum experiments indicated that it inhibited acetylcholine induced 
ileum contractions. It was suggested that 7-epiclusianone (22) exerts its effect by 
blocking the influx of Ca2+.80  
In a more recent study, benzophenone compounds isolated from Hypericum 
thasium Griseb. namely; 3´,4,5´,6-tetrahydroxy-2-O--D-xylosylbenzophenone (31) and 
3,´4,5´,6,-tetrahydroxy-2-O-(4-O-acetyl--D-xylosyl)benzophenone (32), suppressed the 
oxidative burst of neutrophils; however quercetin and isoquercetin showed higher activity 
in this study than the tested benzophenones.83  
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2.9. Toxicology 
Although no toxicological studies on natural isopolyisoprenylated benzophenones 
have been reported, synthetic benzophenones on the other hand are widely used as UV-
screens and cosmetics and have been the subject of a number of toxicological studies. 
UV-screens are topically used and thus may be transcutaneously absorbed. 
Benzophenone-2 (33) binds to both the estrogenic receptors, ER and ER. In addition, 
(33) had powerful estrogenic effects, showing estrogenic effects on uterine tissues.84  
The highest concentration of (33) and its conjugates, BP2-sulfate and BP2-
glucuronide, was observed in urine after 120 minutes of administration (298 g/ml, 1973 
g/ml and 822 g/ml).85 For orally administered 33 it has been shown that the first-pass 
metabolism of the drug is likely to take place in the gastrointestinal lumen, and not in the 
liver, and this would possibly explain the rapid elimination from plasma.85 The 
administration of an intravenous bolus dose of 100 mg/kg of benzophenone (34) to rats 
was followed by the detection of peak plasma concentration after 4 hours.  The peak 
plasma concentration was Cmax = 2.06  0.46 g/ml, after which the concentration of (34) 
slowly declined. The elimination half-life was t1/2= 19 hours and the area under curve 
(AUC) was 47.17  5.52 g/ml h.  Hence, apparent clearance was 2.20  0.22 ml/h/kg.86 
This kinetic study and metabolic profile of (34) in rats was performed using gas 
chromatography and mass spectrometry.86 Only the free, unconjugated forms of the 
metabolites were detected by this method. These included the parent compound, 4-
hydroxybenzophenone and benzohydrol. Even though conjugated benzophenones 
metabolites could not be detected by the reported method, the kinetic behavior of 34 
suggested that it is rapidly absorbed through the gastrointestinal tract. The high 
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absorption rate is mainly due to the degree of lipophilicity of the two aromatic rings. The 
compound (34) rapidly disappears from plasma and the main route of elimination appears 
to be urine; however, rapid elimination from plasma might be due to redistribution to 
other compartment of the body or binding to plasma proteins.86  
Kinetic studies suggest that the synthetic benzophenones are metabolized to 
glucuronide- and sulfate-conjugates before being eliminated. These findings are 
confirmed for garcinol (1) since its oral administration in rats showed an increased 
activity of phase II enzymes, particularly glutathione S-transferase and quinone 
reductase.81 Studies in rat hepatocytes, however suggests that benzophenone compounds 
from Hypericum annulatum Moris are metabolized by the cytochrome P450 enzyme 
CYP2A6.87 Oral administration of 10 mg of garcinol (1) was studied in CD-1 female 
mice.81 The peak plasma level was 12 M and urine level was 2.7 M, suggesting that 
the polyisoprenylated benzophenones are likely to be eliminated through urine.81  
Further toxicological studies and pharmacokinetic studies remain to be conducted 
for garcinol to establish the toxicological and kinetic profile of these compounds and 
metabolites formed during elimination.  
2.10. Conclusions and future prospects 
Polyisoprenylated benzophenones isolated from the genus Garcinia in the 
Clusiaceae family have been widely studied. These secondary metabolites have diverse 
pharmacological properties including antiinflammatory, antimicrobial, and cytotoxic 
effects. Evidence presented in this review suggests that polyisoprenylated benzophenones 
induce apoptosis and arrest the cell cycle early in G1–phase. These compounds prevent 
the transcription and translation of important cell cycle regulators such as cyclins, which 
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are involved in cell progression. Thus they arrest the cell cycle and interrupt cell division 
and inhibit the growth of cancer cells. The mechanism of action involves the inhibition of 
mediators in the Akt/mTOR stress pathway. Although the specific target still remains 
unknown, natural benzophenones might reveal new targets for future therapies. 
Benzophenone compounds have low toxicity and can be synthetically modified to 
produce new active molecules for future anticancer drugs and treatments for other 
diseases.  
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Table 2.1.   Cytotoxic activities of benzophenone compounds isolated from natural sources  
Compounds Source Cell Line Results Comments  
Aristophenone A Garcinia 
xanthochymus 
SW-480 colon cancer cell line IC50 =33.3 (24-33) µM 
 
Aristophenone A exhibited cytotoxicity against SW-480 colon cancer 
cells by inducing apoptosis. [25] 
Cudraphenone A CC50 = 0.17 mM 
CC50 = 0.43 mM 
Cudraphenone B CC50 = 0.036 mM 
CC50 = 0.090 mM 
Cudraphenone C CC50 = 0.092 mM 
CC50 = 0.19 mM 
Cudraphenone D  
 
 
Cudrania 
cochinchinensis  
 
 
 
HSC-2 oral squamous 
carcinoma cell line 
HGF normal human gingival 
fibroblasts  CC50 = 0.052mM 
CC50 = 0.19 mM 
Cudrophenones A-D exhibited stronger cytotoxic activity against 
HSC-2 human oral squamous carcinoma cells compared to HGF 
normal human gingival fibroblasts. [45] 
Positive control : 6-prenyl-4',5,7-trihydroxy-isoflavone 
CC50 = 0.12  mM (HSC-2) 
CC50 = 0.25  mM (HGF) 
Garcinia assigu Raji cells  IC50 = 10.2 ±1.4 µM Cancer chemo-preventive effects could be associated with the free 
radical scavenging properties of garcinol. [52] 
Positive control: Vitamin E  IC50 =22.8±02 µM 
 
 
Garcinia indica  
Colon cancer cell lines: 
HT-29 
HCT-116 
Normal immortalized intestinal 
cells: 
IEC-6 
INT-407 
IC50 =11.4 µM 
IC50 =12.0 µM 
 
IC50 =21.4 µM 
IC50 =19.4 µM 
 
Garcinol exhibited cytotoxicity against colon cancer cells by inducing 
apoptosis, mainly increasing caspase-3 activity. Low concentrations 
<1 µM stimulated the growth of cancer and normal cells ranging from 
10 to 100%. [42] 
Garcinia indica   HL-60 leukemia cell line IC50 = 9.42 µM Garcinol exhibited cytotoxicity against human leukemia cells by 
affecting caspase-3 and caspase-2 activity. Garcinol-induced apoptosis 
was related to the release of mitochondrial cytochrome C and loss of 
mitochondrial intermembrane potential. [43] 
Garcinia indica HL-60  leukemia cell line  EC50 > 10 µM Garcinol exhibited cytotoxicity against human leukemia cells by 
inducing apoptosis. It caused inhibition of NO generation and H2O2 
production. [53] 
 
 
 
 
 
 
 
Garcinol  
 
Garcinia purpurea  
Leukemia cell lines: 
NB4 
K562 
U937 
HL60 
 
Garcinol  was shown to be 
cytotoxic at a dose ranging 
from 5 to 20 µM 
Garcinol exhibited cytotoxicity against leukemia cells by activation of 
caspase 3 and decrease in mitochondrial transmembrane potential, 
subsequently leading to apoptosis. [37] 
Guttiferone A Garcinia 
macrophylla 
A2780 ovarian cancer cell line IC50 = 6.8 µg/ml Guttiferone A exhibited cytotoxicity against human ovarian cancer 
cells. Positive control: Actinomycin D IC50 = 0.003 µg/ml. [33] 
 
Guttiferone E 
 
Garcinia pyrifera KB- oral carcinoma cell line IC50 =10 µM a 
 
Mixture of guttiferone E and xanthochymol exhibited cytotoxicity 
against KB cell lines. Guttiferone E was associated with inhibition of 
the disassembly of microtubules into tubulin with IC50 =1.5 µM.  
Positive control: Paclitaxel IC50 =0.006 µM. [34] 
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Human colon cancer cell lines : 
HCT 116 
HT 29 
SW-480 
 
IC50 =9 (8-12) µM 
IC50 =14 (10-19) µM 
IC50 =17 (14-21) µM 
Guttiferone E caused growth inhibition of colon cancer cells by 
activation of endoplasmic reticulum stress response, subsequently 
affecting the cell cycle. [37] 
 
 
Guttiferone E 
 
 
Garcinia 
xanthochymus 
 
SW-480 colon cancer cell line IC50 =7.5(6.1-7.8) µM 
 
Guttiferone E exhibited cytotoxicity against SW-480 colon cancer 
cells by inducing apoptosis. [25] 
Guttiferone G Garcinia 
macrophylla 
 
A2780 ovarian cancer cell line  IC50 = 8.0 µg/ml Guttiferone G exhibited cytotoxicity against human ovarian cancer 
cells. [33] 
Positive control: Actinomycin D. IC50 = 0.003 µg/ml. 
 
Human colon cancer cell lines : 
HCT 116 
HT 29 
SW 480 
 
IC50 =9 (8-12) µM 
IC50 =13 (10-17) µM 
IC50 =16 (12-20) µM 
 
Guttiferone E caused growth inhibition of colon cancer cells by 
activation of endoplasmic reticulum stress response, subsequently 
affecting the cell cycle. [38] 
 
 
 
 
Guttiferone H 
 
 
 
Garcinia 
xanthochymus 
SW-480 colon cancer cell line IC50 =12.4 (10.5-12.0) µM 
 
Guttiferone H exhibited cytotoxicity against SW-480 colon cancer 
cells by inducing apoptosis. [25] 
 
Guttiferone I IC50 = 4.70  µg/ml 
Guttiferone J 
 
Garcinia virgata  
  
 
KB- oral carcinoma cell line IC50 = 5.0  µg/ml 
Both guttiferone I and guttiferone J exhibited cytotoxicity against KB 
cell lines which was not associated with inhibition of tubulin 
polymerization in the cell. [47] 
Positive control: Taxotere  IC50 = 0.37 ng/ml 
 
Garcinia 
yunnanensis  
HeLa-C3 cervical cancer cell 
line  
Guttiferone K was shown 
to be cytotoxic at a dose of 
20 µg/ml 
It was shown that guttiferone K at a concentration of 20 µg/ml can 
initiate apoptosis in HeLa-C3 cervical cancer cells. Concentration of 
10 µg/ml was not active. [49] 
 
 
 
Guttiferone K 
Rheedia calcicola  A2780 ovarian cancer cell line  IC50 = 3.6  µg/ml 
 
Guttiferone K exhibited cytotoxicity against A2780 human ovarian 
cancer cells. [32] 
Guttiferone L Rheedia calcicola A2780 ovarian cancer cell line IC50 = 3 µg/ml 
 
Guttiferone L exhibited cytotoxicity against A2780 human ovarian 
cancer cells. [32] 
Hyperibone K  IC50 =13.7 mcg/ml 
IC50 =10.0 mcg/ml 
Hyperibone L 
 
Hypericum 
scabrum 
 
A549- lung cancer cell line 
MCF-7 -breast cancer cell line 
 IC50 =9.2  mcg/ml 
IC50 =15.0  mcg/ml 
Both hyperibone K and hyperibone L exhibited cytotoxicity against 
lung and breast cancer cells. [30] 
Isogarcinol 
 
 
Garcinia assigu Raji cells IC50 = 13.3 ±1.3 µM Cancer chemo-preventive effects could be associated with the free 
radical scavenging properties of isogarcinol. [52] 
Positive control : Vitamin E  IC50 =22.8±02 µM 
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Isogarcinol   
Garcinia purpurea 
Leukemia cell lines: 
NB4 
K562 
U937 
HL60 
 
 
Isogarcinol  was shown to 
be cytotoxic at a dose 
ranging from 5 to 20 µM 
Isogarcinol exhibited cytotoxicity against leukemia cells by activation 
of caspase 3 and decrease in mitochondrial transmembrane potential, 
subsequently leading to apoptosis. [37] 
 
 
Garcinia indica 
 
 
MCF-7 breast cancer cell line 
WRL-68 liver cancer cell line 
COLO-320-DM colon cancer 
cell line 
 
 
IC50 =2.85 µM 
IC50 =15.52 µM 
IC50 =4.85 µM 
 
Isoxanthochymol exhibited growth inhibition in MCF-7, WRL-68 and 
COLO-320 cancer cell lines. The same study suggested that 
isoxanthochymol/ xanthochymol mixture (2:1) is more cytotoxic than 
isoxanthochymol alone. [20] 
Positive control: Paclitaxel  
IC50 =0.005 µM (MCF-7) 
IC50 =0.054 µM (WRL-68) 
IC50 =0.01 µM(COLO-320) 
 
 
 
 
 
Isoxanthochymol 
Garcinia pyrifera KB- oral carcinoma cell line IC50 =5.8 µMb Mixture of isoxanthochymol and cycloxanthochymol exhibited 
cytotoxicity against KB cancer cells. [34] 
Positive control:Paclitaxel IC50 =0.006 µM 
 
 
 
 
Clusia rosea  
Leukemia cell lines: 
HL60 WT  
HL60 ADR MDR1+ 
CEM WT  
CEM VBL MDR1+ 
Jurkat WT  
Tanoue WT  
Kasumi WT  
K-562 WT  
  
 IC50 = 2.66±0.66 µM 
 IC50 = 2.56±0.05 µM 
 IC50 = 3.10±0.11 µM 
 IC50 = 3.00±0.06 µM 
 IC50 = 2.30±0.08 µM 
 IC50 = 2.10±0.05 µM 
 IC50 = 2.60±0.25 µM 
 IC50 = 2.10±0.06 µM 
Nemorosone exhibited cytotoxicity against different lines of leukemia 
cells mainly by downregulation of the protein levels of cyclins 
involved in the cell cycle control.  These effects are mainly attributed 
to the negative modification of the Akt/PKB pathway. [36] 
 
 
 
 
 
Nemorosone  
 
Cuban propolis  
Clusia sp. 
HeLa-cell line  
Hep-2 cell line 
PC-3 cell line  
U251- cell line  
 IC50 = 1.6±0.08 µg/ml 
 IC50 = 1.5±0.08 µg/ml 
 IC50 = 3.6±0.65 µg/ml 
 IC50 = 1.9±0.70  µg/ml 
 
Nemorosone exhibited strong cytotoxicity against cervix carcinoma, 
larynx cancer, prostate cancer, and nervous system cancer cell lines. 
[65] 
Ochrocarpinone A IC50 = 6.9 ±0.3µg/ml 
Ochrocarpinone B IC50 = 7.4 ±0.2µg/ml 
Ochrocarpinone C 
Ochrocarpos 
punctatus  
 
A2780 ovarian cancer cell line  
IC50 = 8.2 ±0.3µg/ml 
Ochrocarpinones A-C exhibited cytotoxicity against A2780 ovarian 
cancer cells. [31] 
Tovophenone A EC50 =10.0 µg/ml-1 
Tovophenone B EC50 =9.0 µg/ml-1 
Tovophenone C 
Tovomita 
brevistaminea  
 
KB- oral carcinoma cell line 
EC50 =8.2  µg/ml-1 
The authors considered tovophenones A-C inactive against KB cancer 
cells because EC50 values were bigger than 5 µg/ml-1. [50] 
 
Vismiaguianone A EC50 > 20 µg/ml-1 
Vismiaguianone B EC50 > 20 µg/ml-1 
Vismiaguianone C 
 
 
Vismia guianensis  
 
 
 
EC50 > 20 µg/ml-1 
 Vismiaguianones D-E exhibited moderate cytotoxic activity against 
KB oral cancer cells, while vismiaguianones A-C were inactive. [35] 
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Vismiaguianone D EC50 = 2.4±0.9µg/ml-1 
Vismiaguianone E 
KB- oral carcinoma cell line 
EC50 = 3.3±1.5µg/ml-1 
 
Vismiaguianones D-E exhibited moderate cytotoxic activity against 
KB oral cancer cells, while vismiaguianones A-C were inactive. [35] 
 
 
Garcinia indica 
 
 
MCF-7 breast cancer cell line 
WRL-68 liver cancer cell line 
COLO-320-DM colon cancer 
cell line  
 
 
IC50 =0.475 µM 
IC50 =2.52 µM 
IC50 =0.62 µM 
Xanthochymol exhibited growth inhibition in MCF-7, WRL-68 and 
COLO-320 cancer cell lines. The same study suggested that 
isoxanthochymol/ xanthochymol mixture (2:1) is more cytotoxic than 
xanthochymol alone. [20] 
Positive control: Paclitaxel  
IC50 =0.005 µM (MCF-7) 
IC50 =0.054 µM (WRL-68) 
IC50 =0.01 µM(COLO-320) 
 
Garcinia purpurea 
Leukemia cell lines: 
NB4 
K562 
U937 
HL60 
 
Xanthochymol  was shown 
to be cytotoxic at a dose 
ranging from 5 to 20 µM 
Xanthochymol exhibited cytotoxicity against leukemia cells by 
activation of caspase 3, subsequently leading to apoptosis. [37] 
Garcinia pyrifera KB- oral carcinoma cell line IC50 =10 µM a 
 
Mixture of xanthochymol and guttiferone E exhibited cytotoxicity 
against KB cancer cells. Xanthochymol was associated with inhibition 
of the disassembly of microtubules into tubulin with IC50 =2 µM. [34] 
Positive control: Paclitaxel IC50 =0.006 µM 
Human colon cancer cell lines : 
HCT 116 
HT 29 
SW 480 
 
IC50 =10 (7-13) µM 
IC50 =15 (11-19) µM 
IC50 =17(14-21) µM 
Xanthochymol caused growth inhibition of colon cancer cells by 
activation of endoplasmic reticulum stress response, subsequently 
affecting the cell cycle. [37] 
 
 
 
 
 
 
 
 
 
Xanthochymol 
 
Garcinia 
xanthochymus 
SW 480- colon cancer cell line IC50 =8.3(7.0-8.2) µM 
 
Xanthochymol exhibited cytotoxicity against SW 480- colon cancer 
cells by inducing apoptosis. [25] 
a (Mixture xanthochymol /guttiferone E), b (Mixture of isoxanthochymol/cycloxanthochymol) 
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Table 2.2.  Antibacterial, antiviral, and antiparasitic activities of benzophenone compounds isolated from natural sources  
Compounds Source Strain Results Comments and Reference 
Rheedia gardneriana Trypanosoma cruzi LC50 =260 µg/ml 7-Epiclusianone exhibited tripanocidal activity in vitro. It 
was inactive tested in vivo in mice. [76] 
 Control: Gentian violet LC50 =7.5 µg/ml 
Rheedia brasiliensis Streptococcus mutans MIC= 1.25-2.5 µg/ml 
MBC=10-20 µg/ml 
 
7-Epiclusianone exhibited antibacterial activity. [61] 
Positive control: Chlorhexidine MIC= 1-2 µg/ml 
MBC=8 µg/ml 
 
 
 
 
7-Epiclusianone 
Hypericum sampsonii Staphylococcus aureus  MIC= 4 µg/ml (7.3 µM) 
 
7-Epiclusianone exhibited antibacterial activity against S. 
aureus SA-1199B strain. [22] 
Positive control: Norfloxacin  MIC= 32µg/ml (100 µM) 
7-Epi-garcinol IC50 = 10.1 ± 4.6 µM 7-epi-garcinol exhibited moderate antiplasmodial activity 
against chloroquine-resistant strain of P. falciparum FcB1. 
[77] 
Control: Chloroquine IC50 =  0.078 ± 0.006 7µM 
7-Epi-isogarcinol 
 
 
Moronobea coccinea 
 
 
Plasmodium falciparum 
IC50 = 5.1 ± 1.3 µM 7-epi-isogarcinol exhibited strong antiplasmodial activity 
against chloroquine-resistant strain of P. falciparum FcB1 
strain. [77] 
Paenibacillus larvae 19.7±0.3mm a (35h)  
Chamone I 
 
Clusia grandiflora  Paenibacillus alvei 10±0.6mm a (35h) 
Chamone I exhibited strong antibacterial activity against 
honeybee pathogens. [63] 
 
Coccinone A 
Coccinone B 
Coccinone C 
Coccinone D 
Coccinone E 
Coccinone F 
Coccinone G 
Coccinone H 
Cycloxanthochymol 
 
 
 
 
Moronobea coccinea 
 
 
 
 
 
Plasmodium falciparum 
 
IC50 = 4.3 ± 0.5 µM 
IC50 = 5.5 ± 0.4µM 
IC50 = 9.0 ± 1.2 µM 
IC50 = 7.0 ± 0.9µM 
IC50 = 4.9 ± 0.7µM 
IC50 = 17.0 ± 9.4 µM 
IC50 = 19.2 ± 5.9µM 
IC50 = 16.6 ± 6.1µM 
IC50 = 2.1 ± 0.5 µM 
Coccinones A-E along with cycloxanthochymol exhibited 
strong antiplasmodial activity, while coccinones F-H 
exhibited moderate activity against chloroquine-resistant 
strain of P. falciparum FcB1. [77] 
Control: Chloroquine IC50 =  0.078 ± 0.006 7µM 
IC50 =0.82 µM  Garcinol exhibited leishmanicidal activity in vitro. [75] 
Standard: Miltefosine- IC50 =0.47 µM 
 
Allanblackia monticola 
 
Leishmania donovani 
IC50 =0.33 µM Camboginol exhibited leishmanicidal activity. [75] 
Standard: Miltefosine- IC50 =0.47 µM 
Garcinia bancana (MRSA)-Methicillin-resistant 
Staphylococcus aureus 
MIC=16 µg/ml 
 
Garcinol exhibited antibacterial activity against methicilin-
resistant S.aureus. [60] 
 
 
Garcinol 
(Camboginol)  
 
 
Garcinia purpurea  (MRSA)-Methicillin-resistant 
Staphylococcus aureus 
MIC= 6.25-12.5 µg/ml 
 
Garcinol exhibited strong antibacterial activity against 
MRSA. [59]Control: Vancomycin MIC= 6.25 µg/ml 
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Moronobea coccinea Plasmodium falciparum IC50 = 12.6 ± 4.8 µM Garcinol exhibited moderate antiplasmodial activity against 
chloroquine-resistant P. falciparum FcB1 strain. [77] 
Control: Chloroquine IC50 =  0.078 ± 0.006 7µM 
Garciosaphenone A Garcinia speciosa HIV-1 IC50 =23.9 µg/ml Garciosaphenone A exhibited HIV-1 inhibitory activities. 
[69] 
Garcinia intermedia   Trypanosoma cruzi  MC100=100 µM (Epimastigotes) 
MC100=83µM (Trypomastigotes) 
Guttiferone A exhibited trypanocidal activity. [74] 
Symphonia globulifera  Leishmania donovani IC50 =0.16 µM Guttiferone A exhibited strong leishmanicidal activity. 
[75] 
Standard: Miltefosine- IC50 =0.47 µM 
 
 
Guttiferone A 
Symphonia globulifera Plasmodium falciparum IC50 = 3.17 µM Guttiferone A exhibited antiplasmodial activity. [78] 
Allanblackia monticola Leishmania donovani IC50 =0.20 µM Guttiferone F exhibited strong leishmanicidal activity.[75] 
Standard: Miltefosine- IC50 =0.47 µM 
 
Guttiferone F 
Allanblackia 
stuhlmannii 
HIV-1 EC50 =23µg/ml Gutifferone F exhibited HIV-1 inhibitory activity in vitro. 
[22] 
 
 
 
Guttiferone I  
 
 
 
Garcinia smeathmannii 
Citrobacter freundii 
Enterobacter cloaclae 
Proteus vulgaris 
Bacillus megaterium 
Streptococcus faecalis 
MIC= 1.22 µg/ml 
MIC= 1.22 µg/ml 
MIC =1.22 µg/ml 
MIC =0.61 µg/ml 
MIC =0.61 µg/ml 
Guttiferone I exhibited antibacterial activities against both 
gram-positive and gram-negative bacteria. [21] 
Control: Gentamycin  
MIC= 4.88 µg/ml 
MIC= 4.88 µg/ml 
MIC= 1.22 µg/ml 
MIC= 2.44 µg/ml 
MIC= 2.44 µg/ml 
Garcinia purpurea (MRSA)-Methicillin-resistant 
Staphylococcus aureus 
MIC= 12.5 µg/ml (MRSA) Isogarcinol exhibited antibacterial activity against MRSA. 
[59] 
Control: Vancomycin MIC= 6.25 µg/ml 
 
 
Isogarcinol 
Moronobea coccinea Plasmodium falciparum IC50 = 3.5 ± 1.1 µM Isogarcinol exhibited strong antiplasmodial activity against 
chloroquine-resistant strain of P. falciparum FcB1. [77] 
Control: Chloroquine IC50 =  0.078 ± 0.006 7µM 
Garcinia smeathmannii Bacillus cereus 
Bacillus stearothermophylus 
MIC= 9.76 µg/ml 
MIC= 4.88 µg/ml 
 
Isoxanthochymol exhibited antibacterial activities against 
gram-positive bacteria. [21] 
Control: Gentamycin  
MIC= 1.22 µg/ml 
MIC= 4.88 µg/ml 
 
 
Isoxanthochymol 
Garcinia subelliptica (MRSA)-Methicillin-resistant 
Staphylococcus aureus 
MIC >25 µg/ml* Mixture of isoxanthochymol/cycloxanthochymol exhibited 
weak antibacterial activity. [59] 
Control: Vancomycin MIC= 6.25 µg/ml 
Microsphaerin A 
Microsphaerin B 
Microsphaerin C 
 
 
 
(MRSA)-Methicillin-resistant 
Staphylococcus aureus 
IC90 =3.0 µM 
IC90 =3.0 µM 
IC90 =5.0 µM 
Microsphaerins A-C exhibited strong antibacterial activity 
against MRSA. [67] 
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 a Total inhibition, bAnamorphic fungus , c Plant endophytic fungus, d Marine fungus, * Mixture of isoxanthochymol/cycloxanthochymol     
 
 
 
 
Microsphaerin D 
 
 
 
Microsphaeropsis sp. b 
(F2076) and (2078) 
 
 
 
 
 
Staphylococcus aureus 
MRSA 
Enterococcus faecalis 
Streptococcus pneumonia 
Bacillus subtilis 
Escherichia coli 
Klebsiella pneumoniae 
Moroxella catarrhalis 
Haemophilus influenzae 
Pseudomonas aurogenosa 
IC90 =1.3 µM 
IC90 =1.0 µM 
IC90 =1.3 µM 
IC90 =3.6 µM 
IC90 =3.0 µM 
IC90 >50 µM 
IC90 >50 µM 
IC90 =1.3 µM 
IC90 >50 µM 
IC90 >50 µM 
Microsphaerin D exhibited strong antibacterial activity 
against gram-positive bacteria; but it was not active against 
gram-negative bacteria with one exception (K. 
pneumoniae). [67] 
Nemorosone II Clusia grandiflora Paenibacillus larvae 
Paenibacillus alvei 
19.5±1.6 mm a (35h)  
2.3 ± 2.3 mm a (35h) 
Nemorosone II exhibited strong antibacterial activity 
against honeybee pathogens. [63] 
Pestalachloride A Fusarium culmorum 
Gibberrella zeae 
Verticillium aibo-atrum 
Pestalachloride B Fusarium culmorum 
Gibberrella zeae 
Verticillium aibo-atrum 
Pestalachloride C 
 
 
 
 
Pestalotiopsis adustac 
Fusarium culmorum 
Gibberrella zeae 
Verticillium aibo-atrum 
IC50 =0.89±0.10µM / MIC=7.2 µM 
IC50 =54.4±0.8µM / MIC=114.4µM 
IC50 =58.3±1.4µM / MIC=114.4µM 
 
IC50 =4.7±0.2µM / MIC=49µM 
IC50 =1.1±0.08µM / MIC=12.2µM 
IC50 =7.9±0.2µM / MIC=12.2µM 
 
IC50 > 118.5µM / MIC >236.9µM 
IC50 > 118.5µM / MIC >236.9µM 
IC50 > 118.5µM / MIC >236.9µM 
Pestalachlorides A-B exhibited strong antifungal activities 
against plant pathogens. Pestalachloride C did not exhibit 
significant activity against the same plant pathogens. [43] 
 
 
Pestalone  
 
 
Pestalotia sp.d 
(MRSA)-Methicillin-resistant 
Staphylococcus aureus 
 
Vancomycin –resistant 
Enterococcus faecium  
 
MIC= 37 ng/ml 
 
 
MIC= 78 ng/ml 
Pestalone exhibited strong antibacterial activity against two 
lines of antibiotic resistant bacteria. [66] 
Vismiaphenone D 
Vismiaphenone E 
Vismiaphenone F 
Vismiaphenone G 
 
Vismia cayennensis 
HIV EC50 =11 µg/ml 
Inactive 
Inactive 
Inactive 
Only vismiaphenone D exhibited HIV inhibitory activity, 
while vismiaphenones E-G were inactive. [70] 
Xanthochymol Garcinia subelliptica (MRSA)-Methicillin-resistant 
Staphylococcus aureus 
 
MIC= 3.13-12.5 µg/ml (MRSA) Xanthochymol exhibited strong antibacterial activity 
against MRSA. [59] 
Control: Vancomycin MIC= 6.25 µg/ml 
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Figure 2.1. General structure of polyisoprenylated benzophenone 
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Figure 2.2. Polyisoprenylated benzophenones from natural sources and synthetic analogues 
(compounds 1-34) 
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Figure 2.2. (Continued) Polyisoprenylated benzophenones from natural sources and synthetic 
analogues (compounds 1-34) 
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Figure 2.2. (Continued) Polyisoprenylated benzophenones from natural sources and synthetic 
analogues (compounds 1-34) 
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Figure 2.2. (Continued) Polyisoprenylated benzophenones from natural sources and synthetic 
analogues (compounds 1-34) 
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Chapter 3 
Benzophenones and Biflavonoids Antioxidants from Garcinia intermedia fruits 
(Clusiaceae) 
FRUI 
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3.1. Introduction 
As part of our ongoing studies of antioxidants from tropical edible fruits, 
we have studied Garcinia intermedia (Pittier) Hammel.88 Garcinia intermedia is a 30 m 
high tree with yellow latex, native to the Central American lowland tropical rain-forest. 
The leaves are opposite, leathery, dark-green on the adaxial surface, brownish on the 
abaxial surface, 8-15 cm long and 2-5 cm wide, although the leaf-shape can be elliptic, 
lanceolate or oblong. The flowers are white, joined in clusters and have four petals. The 
male flowers have 25-30 stamens. The fruits are yellow and are oval or oblong, 2-3 cm 
long, with a smooth thin skin. The seeds are 1-2. The fruit is sweet and matures from late 
January to March. It is the only Central American member of this genus with edible 
exocarp. The wood has numerous gum ducts and it is immune to insects and it is 
sometimes grown as an ornamental tree.89 Garcinia intermedia has many different 
common names. It is called “waiki-plum” in Belize, “arrayán” and “palo de frutilla” in 
Guatemala, “chaparrón” in El Salvador, “caimito” in Honduras, “jorco” in Costa Rica 
and “sastra” in Panama. It is cultivated locally in Brazil and in the Philippines where it is 
called “limão do matto” or “berba”, respectively.89  
Guttiferone A, 8-desoxygartanin, podoscarpusflavone A, amentoflavone, 
and friedelin have previously been identified in the leaves of this species.74 To our 
knowledge no previous study has been done on the fruits of this species. Previous studies 
have found that prenylated benzophenones have antiviral23 and insecticidal activities.90 
We have found that prenylated benzophenone compounds from Garcinia xanthochymus 
fruits have antioxidant and weak cytotoxic effect against colon cancer cells, SW480.25 
Gene expression studies of cancer cells suggested that prenylated benzophenone 
compounds interfere with the mitochondrial membrane potential and subsequently 
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activates the endoplasmatic stress and cellular energy stress response pathways. 
Guttiferone compounds induce cell-cycle arrest in G1-phase and induce apoptosis,38  
suggesting that these compounds exert chemopreventive effects against cancer by 
arresting their cell cycle of cancer cells.  
It has been suggested that benzophenone compounds inhibit the 
disassembly of microtubules, thus inhibiting cell replication through yet another 
mechanism.34 Nevertheless, the specific cellular target of benzophenones exerting 
cytotoxicity has not been described until now. Thus we tested the compounds isolated 
from G. intermedia for inhibitory activity of the following cell cycle regulators; 
DYRK1A, CK1, CDK5, and GSK3.  
3.2. Results and discussion 
In our study of antioxidants from the fruits of G. intermedia we have 
identified six benzophenones; guttiferone A (1), guttiferone E (2), isoxanthochymol (3), 
xanthochymol (4), aristophenone (5) maclurin (6), and two biflavonoids, volkensiflavone 
(7) and fukugetin (8). Identification was made through comparison to previously isolated 
standards and based on literature data (Fig. 3.1). Compound 9 was analyzed by 
HRESIMS and by 1D and 2D NMR experiments, which led to the identification and 
characterization of its structure (Fig. 3.2). The compound showed the UV absorption at 
max 233 and 279 nm, which is distinctive of benzophenone compounds. The HRESIMS 
spectrum showed a protonated molecule [M+H]+ of m/z 619.3568, which corresponded to 
a molecular formula C38H50O7 calculated for 618.3557 and containing 14 degrees of 
unsaturations.  
The 1H-spectrum of 9 (Fig 3.3) showed an aromatic AMX splitting system 
with resonances at  7.19 ppm d (J = 1.8 Hz), 7.06 ppm dd (J = 8.2, 1.8 Hz), and 6.72 
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ppm d (J = 8.2 Hz).  Three olefinic protons were detected at  5.03 ppm, 4.95 ppm and 
4.90 ppm, indicating the presence of three isoprenylated substituting groups. The broad 
proton signals at  4.90 and 4.76 ppm suggested the presence of a terminal methylene. 
The 13C-NMR spectrum (Fig. 3.4) of compound 9 showed three signals at  192.0, 193.0 
and 213.0 ppm, indicating the presence of three carbonyl groups. The resonance signals 
of substituted aromatic carbons were detected at  133.5, 145.7 and 150.0 ppm. The 
carbon signal at  75.6 ppm was assigned as C-34 and it corresponded to a methine signal 
in the DEPT experiment (Fig. 3.5). The HSQC experiment (Fig. 3.6) confirmed that the 
carbon at  75.6 ppm (C-34) was coupled to a proton at  3.94 ppm (d, J= 5.31).  
Moreover, the HMBC experiment (Fig. 3.7) showed that the proton signal at  4.90 brs 
ppm (H-32) correlates with carbon at  18.0 ppm (C-33), and to carbon at  75.6 ppm (C-
34).  Furthermore, the proton at  1.67 ppm (H-33) showed strong correlations to carbons 
at  17.6 ppm (C-33), 75.6 ppm (C-34), 110.2 ppm (C-32) and 148.5 ppm (C-31).  In the 
HMBC experiment, the proton at  4.76 brs ppm (H-32a), which appears as broad singlet 
in the proton spectrum, correlated to carbon at  17.6 ppm (C-33) as well as to carbon at 
 75.6 ppm (C-34). The COSY spectrum showed a correlation between proton at  3.94 
(H-34) ppm and proton at  4.90 brs (H-32b) ppm.  There are five methylene signals in 
the 13C DEPT 135 spectrum. 
The aromatic proton at  7.19 ppm (H-12) showed HMBC correlations to 
carbons at  123.9 ppm (C-16), 145.7 ppm (C-13), 150.0 ppm (C-14), and 199.0 ppm (C-
10), this last correlation links the aromatic 3,4-dihydroxybenzoyl moiety to one of the 
carbonyl carbons (C-10).  Similarly, the aromatic proton at 7.06 ppm (H-16) showed 
HMBC long-range correlations to carbons at  116.9 ppm (C-12), 150.0 ppm (C-14), and 
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199.0 ppm (C-10).  Proton at  6.72 ppm (H-15) correlates to carbons at  133.5 ppm (C-
11), 145.7 ppm (C-13), and 150 ppm (C-14). Moreover, proton at  2.80 ppm (H-30) 
correlates to carbons at  39.4 ppm (C-29). Proton at  2.60 ppm (H-17) correlates to 
carbon at  68.7 ppm (C-4), 132.7 ppm (C-19), 193.0 ppm (C-3), and 213.0 ppm (C-9). In 
the bicyclo[3.3.1]nonane structure proposed, the proton at  2.00 (H- 7b) ppm correlates 
to carbons at  39.4 ppm (C-29), 61.7 ppm (C-8), 192.0 ppm (C-1), and 213.0 ppm (C-9).  
In addition, strong HMBC cross-peaks were identified from the methyl 
group at  1.22 ppm s (H-22) correlating to carbon at  40.6 ppm (C-6) and 50.2 ppm (C-
5). Proton at  1.61 ppm was assigned as H-27 showed correlations coupling to carbon at 
 17.8 ppm (C-28), 125.9 ppm (C-25), and 132.6 ppm (C-26). 
During isolation of benzophenones and biflavonoids, antioxidant activity 
was measured using the DPPH assay, previous to isolation of phytochemical constituents. 
The methanol extract displayed low antioxidant activity (IC50= 118.1  0.94 µg/ml) in the 
DPPH assay. The chloroform and ethyl acetate partitions showed high activity, IC50= 
23.4  1.28 µg/ml and IC50= 41.4  3.66 µg/ml respectively, while the n-butanol partition 
only had a moderate activity (68.0  1.41 µg/ml). The antioxidant activity of guttiferone 
A (IC50= 46 µM) is comparable to that of gallic acid (IC50= 35 µM). The antiproliferative 
effect of guttiferone A against HT-29 colon cancer cells was IC50= 15.8 µM (tested by 
Dr. Linda Saxe-Einbond). 
Fukugetin, volkensiflavone, and guttiferone A were analyzed for cyclin 
dependent kinase activity and cell cycle regulation by DYRK1A, CK1, CDK5, and 
GSK3; however, the tested compound did not show any activity on these cell cycle 
mediators.  
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Experimental Section 
3.3. General experimental procedures 
1H, 13C, DEPT, HSQC, and HMBC NMR spectra were measured using a 
Bruker Avance 300 MHz spectrometer. Sephadex LH-20 (Pharmacia Fine Chemicals, 
Piscataway, NJ) and reversed-phase C18 silica gel (J.T. Baker, Phillipsburg, NJ) was used 
for gel-filtration and column chromatography. MeOH (J.T Baker, Phillipsburg, NJ) was 
used for extraction and isolation. TLC plates RP18 F254 (Merck, Darmstadt, Germany) 
were used to monitor separation and isolation. Preparative HPLC was carried out to 
separate a mixture of guttiferone A and isoxanthochymol using a Waters 600 controller 
with Waters 486 tunable absorbance detector and a Phenomenex Luna C18 column (250 
x 21.2 mm, 10 µm) and Phenomenex Synergi Hydro-RP C18 column (250 x 4.6 mm, 5 
µm). A Waters 2695 separation module and a 996 photodiode array detector with a 
Phenomenex Luna C18 column (250 x 4.6 mm, 5 µm) (Torrance, CA) were used to 
analyze the main constituents. Molecular weights were obtained using a ThermoFinnigan 
electrospray LCQ mass spectrometer in the negative mode. Absorbance was measured 
using a microplate reader (Molecular Devices Versamax). 
3.3.1. Plant material 
Fruits of Garcinia intermedia were obtained from the Broward County Rare 
Fruit and Vegetable Council, Florida. The collected fruits were shipped overnight and 
stored at -20 °C at the Phytochemistry Laboratory, Lehman College, City University of 
New York, Bronx, NY. A voucher specimen is kept at The William and Lynda Steere 
Herbarium at the New York Botanical Garden, Bronx, NY. 
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3.3.2. 1,1-Diphenyl-2-picrylhydrazyl (DPPH) assay 
The DPPH antioxidant assay was performed according to previously 
described procedures.91 Samples were dissolved in DMSO and further diluted before 
being transferred to a 96-well microtiter plate. Each well contained 150 µL ethanolic 
solution of DPPH (400 mM) and 50 µL of sample solution. The microtiter plates were 
incubated at 37°C for 30 min and their absorbance were measured at UVmax 515 nm using 
a microplate reader (Molecular Devices Versamax). The obtained data were used to 
determine the concentration of the sample required to scavenge 50% of the DPPH free 
radicals (IC50). The percent inhibition was plotted against concentration and the IC50 was 
obtained from the fitted linear curve. In the experiments, the negative controls, ethanol 
and DMSO, showed no antioxidant activity. Ascorbic acid was used as a positive control 
(IC50 = 15 µg/mL). The CHCl3 partition displayed highest antioxidant activity in the 
DPPH assay (IC50 = 23.4  1.28 µg/mL) and was further analyzed. The antioxidant 
activity of guttiferone A (IC50 = 46 µM) is comparable to that of gallic acid (IC50 = 35 
µM).  
3.3.3. Extraction and isolation 
To obtain minor benzophenone constituents, the seeds of G. intermedia 
(358 g) were extracted three times in 2000 mL MeOH at room temperature. The MeOH 
extract was evaporated in vacuo, and it yielded a residue, which was suspended in water 
and then sequentially partitioned with 300 x 3mL CHCl3, EtOAc, and BuOH. The EtOAc 
partition (6.95 g) was chromatographed over an open column with silica gel reversed-
phase C18, using a gradient solvent system composed of ammonium acetate (10 mM) and 
MeOH, starting at (50:50)(0:100). Thirteen fractions were obtained and analyzed. 
Fractions D through F were combined (8.6 mg). This sample contained a binary mixture 
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of benzophenone compounds and was analyzed by 1D and 2D NMR. Structure 
elucidation and identification of compound 9 was achieved from these experiments.  
Analytical HPLC was used for further purification and to obtain compound 
9, using a Synergi Hydro-RP column with a solvent system composed of ammonium 
acetate buffer (10 mM) and MeOH. A linear gradient system was used; starting from 
(50:50)(35:65), over 5 minutes, then running from (35:65)(25:75), over 18 minutes. 
Then, finally, the isocratic condition (5:95) was run for 5 minutes, before restoring initial 
conditions (50:50) for 10 min. The flow rate was 1 mL/min. Separation was monitored at 
max 280 nm. A sample of 1.5 mg containing compound 9 was obtained for further NMR 
analysis to identify compound 9. 
The separations and fractions were monitored and combined using RP18-
TLC, developed in a mixture composed of ammonium acetate buffer  (10 mM): MeCN 
(5:95). The constituents were detected by spraying the TLC plate with a reagent 
composed of 10% H2SO4 and 1% vanillin in EtOH and followed by heating. Analysis 
during separations was performed using reversed-phase HPLC, with a solvent system 
composed of ammonium acetate buffer  (10 mM) and MeCN; a linear gradient of the 
mixture (95:50:1) was run over 45 minutes at a flow rate of 1 mL/minute, holding 
100% MeCN for 10 minutes. In addition, fractions were monitored by LC-MS.   1H, 13C, 
DEPT, HSQC and HMBC experiments were recorded in acetone-d6. 
Guttiferone A (1): The UV (MeOH) absorption was max  233 and 279 nm; 1H-NMR (300 
MHz, acetone-d6) The molecular weight obtained by negative electrospray ionization 
mass spectrometry was m/z 601. The structure was identified by NMR and in compared 
to data in previously published literature.68  
  
53
Guttiferone E (2): The UV (MeOH) absorption was max 241 and 279 nm. It was 
identified by HPLC spiking experiment using available standards.  
Isoxanthochymol (3): The UV (MeOH) absorption was max 233 and 279 nm. The 
molecular weight obtained by negative electrospray ionization mass spectrometry was 
m/z 601. The structure was identified by NMR and by comparison to previously 
published literature data.68 
Xanthochymol (4): The UV (MeOH) absorption was max 241 and 279 nm. It was 
identified by HPLC spiking experiment using available standards.  
Aristophenone (5): The UV (MeOH) absorption was max 243 and 310 nm. The 
molecular weight obtained, by negative electrospray ionization spectroscopy, was m/z 
534. 
Maclurin (6): The UV (MeOH) absorption was max 228, 279 and 360 nm. The molecular 
weight obtained, by negative electrospray ionization spectroscopy, was m/z 262. 
Volkensiflavone (7): The UV (MeOH) absorption was max 215, 288 and 323 nm. The 
molecular weight obtained, by negative electrospray ionization spectroscopy, was m/z 
540.  
Fukugetin (8): The UV (MeOH) absorption was max 214, 289 and 329 nm. The 
molecular weight obtained, by negative electrospray ionization spectroscopy, was m/z 
556. 
Compound (9): yellow oil; UV (MeOH) absorption was max 213, 230 and 280 nm; 1H-
NMR (300 MHz, acetone-d6) and 13C-NMR (300 MHz, acetone-d6). See Table 3.1; 
HRESIMS was m/z 619.3568 [M+H] + (calcd for C38H50O7, 618.3557). 
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Figure 3.1. Previously known compounds identified in fruits of G. intermedia 
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Table 3.1. NMR Data for compound 9 (in acetone-d6)  
Position 
13C 1H 

H HMBC 
connectivities
b
 
1 192  7A, 29B 
2 119.3   
3 193  17AB 
4 68.7  17AB 
5 50.2  7B, 22, 23 
6 40.6 1.76 m 7A, 7B, 22, 23 
7 38 2, 1.97 m 6, 24 AB, 29A 
8 61.7  7A, 7B 
9 213  7B, 17AB 
10 199  12, 16 
11 133.5  15 
12 116.9 7.19 d (1.8) 16 
13 145.7  12, 15 
14 150  12, 15, 16 
15 114.6 6.72 d (8.2)  
16 123.9 7.06 dd (8.2, 1.8) 12 
17 26.1 2.6  
18 122 5.03 20, 21 
19 132.7  17AB, 20, 21 
20 25.9 1.69 s 18, 21 
21 17.9 1.64 s 18, 20 
22 19.3 1.221 s 23 
23 30.1 1.216 s 22 
24 30.1 2.07 6, 7AB 
25 125.9 4.95 27, 28 
26 132.6  27, 28 
27 25.8 1.61 s 28 
28 17.8 1.48 s 27 
29 39.4 2.15, 1.90 7AB, 30 
30 42.6 2.80 29A, 29B, 34 
31 148.5  33 
32 110.2 4.90 brs, 4.76 brs 33 
33 17.6 1.67 32B 
34 75.6 3.94 29A, 32A, 32B, 33 
35 125.8 4.89 37, 38 
36 132.5  37, 38 
37 25.8 1.61 s 38 
38 17.7 1.68 s 37 
a
Proton coupling constants are given in parentheses; carbon types were confirmed with 
DEPT and edited-HSQC experiments.  
b
Protons correlating with carbon resonance.   
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Figure 3.2. Proposed structure of new polyisoprenylated benzophenone 9 
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Figure 3.3. 1H spectrum of compound 9 in CD3OD (300 MHz) 
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Figure 3.4. 13C spectrum of compound 9 in CD3OD (300 MHz) 
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Figure 3.3 13C spectrum 3-28-C in CD3OD 
A 
B 
C 
Figure 3.5. Spectra of compound 9 in CD3OD (300 MHz): A 13C spectrum B DEPT 135 C 
DEPT 90 
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Figure 3.6. HSQC spectrum of compound 9 in CD3OD (300 MHz) 
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Figure 3.7. HMBC spectrum of compound 9 in CD3OD (300 MHz) 
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Chapter 4 
Quantitative HPLC-PDA Analysis of Benzophenones and Biflavonoids in Eight 
Garcinia Species 
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4.1. Introduction 
Fruits and vegetables are rich in essential antioxidant nutrients, including the pro-
vitamin -carotene and vitamins C and E. Additional antioxidants, such as polyphenols 
ingested through the daily diet increase the antioxidant capacity of plasma1 and are an 
important source of compounds protective against the damaging effects of free-radicals2. 
The benefits of certain non-nutritional antioxidants such as flavonoids have been 
evaluated in several epidemiological studies.3, 4, 5 In particular, it has been shown that a 
diet rich in fruits and vegetables significantly reduces the incidence and mortality rate of 
cardiovascular diseases,6 and a high intake of fruit and vegetables has protective effects 
against cancer.7, 8  
The Garcinia fruits are used frequently as food and sold in local markets in the 
tropics. Garcinia mangostana L., native to Southeast Asia and commonly called 
“mangosteen” and the “queen of fruits”,92 is highly regarded among connoisseurs who 
consider it as one of the best tasting fruits.89 Mangosteen has been marketed to consumers 
as a “superfruit” with health-beneficial effects in functional food and in dietary 
supplements.93 The nonedible pericarp of G. mangostana has been used in Thai 
traditional medicine to treat wounds, ulcers and dysentery.94 The fruit of G. 
xanthochymus Hook. f. or “gamboge“ are native to India and is used in traditional 
medicine for treating diarrhea and dysentery.25 The fruit is traditionally used as jellies or 
preserve, as a tamarind substitute in cooking and as a yellow dye for fabric and 
watercolors. Similarly, the fruits of G. spicata Hook.f. are native to South India and are 
traditionally used to dye silk.95 The fruit of G. livingstonei T. Anderson is also called 
“imbe” and is native to East Africa. It is widely distributed from Durban in South Africa 
to Somalia and near the valleys of the Zambezi and Limpopo rivers.96,97 Garcinia 
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intermedia (Pittier) Hammel is the only species of the genus native to Central America. 
The fruits are used for jellies and preserves.89 The fruits are acidic and have two to three 
seeds. The fruits of G. hombroniana Pierre are native to Malaysia, commonly called 
“seashore mangosteen” and are the closest relative of “mangosteen”.12 Garcinia kola 
Heckel is traditionally used by Western African healers, and is commonly used in West 
Africa as a chewing stick to maintain dental health.98,99 The fruits of Garcinia aristata 
Borhidi, native to Cuba, are also called the “Cuban mangosteen”, and have been found 
growing in endangered habitats.64 Garcinia species display a high diversity of floral 
morphology which led to the recognition of several segregated genera; however, a recent 
taxonomic revision and a phylogenetic studies support a broad circumscription of 
Garcinia, including the earlier segregated genera Ochrocarpus Thouars, Pentaphalagium 
Warb., Rheedia L., and Tripetalum Schumann.12 
In contrast to polyphenols, which are common in edible fruits from a large 
number of plant families, the production of polyisoprenylated benzophenones and 
xanthones is more restricted to families such as Clusiaceae and the Moraceae. In this 
work the distribution of these constituents is analyzed in fruits of eight species of 
Garcinia by high-performance liquid chromatography with a photo-diode array detector 
(HPLC-PDA). Antioxidant properties and DPPH activity were tested, and the total 
phenolic content (TPC) was determined by the Folin-Ciocalteau assay. This is the largest 
comparative study of benzophenones and biflavonoids in eight Garcinia species.  
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4. 2. Materials and methods 
4.2.1. Chemicals  
The purity of the standards (Fig. 4.1) was determined by HPLC and the following 
values were obtained, xanthochymol = 78.8%, guttiferone E = 79.7%, guttiferone A = 
96.0%, fukugetin = 100%, volkensiflavone = 100%, amentoflavone = 99.3%, and 
fukugeside = 98.1%. The standards, guttiferone E, xanthochymol, guttiferone A, 
volkensiflavone, fukugetin, and fukugeside (Fig. 4.1) have been previously isolated and 
identified.25 The standard amentoflavone was purchased from ChromaDex (Santa Ana, 
CA). Ammonium acetate was obtained from Sigma Aldrich.  HPLC grade methanol and 
acetonitrile solvents were obtained from J.T. Baker (Philipsburg, NJ).  Buffer was 
prepared using, deionized water. 
4.2.2. Plants 
Fruits of G. xanthochymus, G. spicata, G. hombroniana, G. aristata, and G. intermedia 
were collected by Margaret J. Basile at the Rare Fruit and Vegetable Council of Broward 
County (FL) and the Fruit and Spice Park (Homestead, FL). The fruits were shipped 
overnight on dry ice and frozen, and stored at - 20 ºC in the laboratory until extraction. 
Voucher specimens were prepared and were deposited at the Lynda Steere Herbarium at 
the New York Botanical Garden (Bronx, NY). The fruits of G. mangostana were 
purchased in New York City. The chewing sticks of G. kola were a donation from the 
Lewis’ collection and had been purchased from local markets in Cameroon. 
4.2.3. Methods 
Separation and identification were achieved using a Waters 2695 separation 
module (Milford, MA) and a 2996 photodiode array detector operated with Empower 
software. Separation was carried out on a Phenomenex Synergi® Hydro RP-18 column 
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(250 x 2.00 mm id, 4 µm) (Torrance, CA) using a mobile phase and solvent system 
composed of 10 mM ammonium acetate buffer (A) and acetonitrile (B) at a flow rate of 
0.2 ml / min, and a temperature of 30 º C. The gradient profile consisted of three periods 
(0 - 15 min) 25 - 30 % B; (15 - 30 min) 30 - 51 % B; (30 - 100 min) 51 B %, maintaining 
isocratic conditions for the last period. Prior to the next sample injection, the column was 
washed with 100 % B for 10 min before being equilibrated at the initial conditions for 15 
minutes. The UVvis spectra were measured from 200 nm to 500 nm. Chromatograms 
were extracted at max = 280 nm. A sample of 2 l was injected into the column in 
triplicate (Fig. 4.2). The retention times are presented in Table 4.1. Limits of detection 
(LOD) were determined based on a signal-to-noise ratio of 3:1. The limits of detection 
was 260 ng/ml for amentoflavone and 330 ng/ml for guttiferone A (Table 4.1).  
4.2.4. Standard dilutions 
Stock solutions were prepared by dissolving individual standards in HPLC grade 
MeOH. The concentrations were xanthochymol, 3.4 mg/ml; guttiferone E, 2.2 mg/ml; 7.2 
mg/ml for guttiferone A; 2.7 mg/ml for volkensiflavone; 10.1 mg/ml for fukugetin; 6.5 
mg/ml for amentoflavone and 12.7 mg/ml for fukugeside. Stock solutions were then 
diluted with MeOH to provide ten concentration levels to determine the standard 
calibration curves. The samples were filtered using Phenex RC 0.45 m membrane filter 
(Millipore, Germany) and injected in triplicate into the HPLC. 
4.2.5. Sample preparation 
The fruits (10.00 g) were lyophilized and dried before being extracted three times 
in 200 ml MeOH for 1 hour at room temperature. The extracts were then dried in vacuo at 
40 ºC and then dissolved to 100 ml in a volumetric flask. Aliquots of 2 ml were stored for 
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each extract in the freezer at – 20º C before HPLC analysis. Samples were filtered 
through 0.45 m membrane filters, before injection into the HPLC. 
4.2.6. Validation 
Recovery tests were performed according to American Association of Analytical 
Chemists guidelines for single laboratory validation (Section 3.3.2). Accuracy of the 
method was achieved by determination of the recovery through standard addition. Three 
different concentrations of amentoflavone (3.1, 1.5, and 0.8 mg/ml) were used to spike 
0.50 g of lyophilized G. spicata fruit. Three different concentrations of guttiferone A 
(6.8, 3.4, and 1.7 mg/ml) were used to spike 0.50 g of lyophilized G. spicata fruit. The 
recoveries were determined by subtracting the values obtained from the control (unspiked 
matrix) from the sample containing added spiked standard, divided by the amounts 
added. Recovery was 96.2%, 98.7%, and 113.0% for amentoflavone, and for guttiferone 
A recovery was 96.1%, 98.3%, and 98.7%. Guttiferone A was added at three levels, 
150%, 70%, and 30%.  The obtained values indicated that MeOH is an acceptable 
extraction solvent.  
4.2.7. Precision 
The spiked samples were injected three times and the relative standard deviation 
values (RSD %) were calculated for the peak area and were considered as a measure of 
precision. The relative standard deviations (RSD %) from the recovery experiments 
ranged from 0.07 % - 0.59 %. 
4.2.8. DPPH assay 
The DPPH antioxidant assay was performed according to procedures described by 
Smith et al.91 Samples for the experiments (10 mg) were dissolved in 6 ml 
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dimethylsulfoxide (DMSO) and further diluted to appropriate concentrations (15.6, 31.3, 
62.5, 125, and 250 g/ml) before being transferred to a 96-well microtiter plate. The 
experiments were performed in duplicate. Each well contained 150 l ethanolic solution 
of DPPH (400 M) and 50 l of sample solution. Controls were prepared with 150 l 
ethanol and DMSO. The microtiter plates were incubated at 37 C for 30 min and the 
absorbance was measured at 515 nm using a microplate reader (Molecular Devices 
Versamax). In the experiments, the negative controls, ethanol and DMSO, showed no 
antioxidant activity. Ascorbic acid was used as a positive control. Percent inhibition by 
sample exposure was determined by comparison with a DMSO-treated control group. 
4.2.9. Total phenolic content 
The aliquots of the extracted fruits were used for testing the total phenolic content 
present in samples. A sample of 100 l of was added to 1 ml of 10% (v/v) Folin-
Ciocalteau reagent incubated for 5 minutes and then 1 ml of 10% NaCO3 was added. The 
mixture was incubated for 90 minutes before reading absorbance at 765 nm using a 
microplate reader (Molecular Devices Versamax). All aliquots of analyzed samples and 
gallic acid standards were analyzed in triplicate. Gallic acid equivalents (GAE) were 
established for 1 gram of dry fruit.  
4.2.10. Statistical analysis 
Values are averages of three determinations and the standard deviation. The 
results were analyzed for variation (ANOVA) and statistical significance by Tukey-
Kramers test. Software JMP version 8 was used for data analysis. Pearson´s correlation 
coefficient was calculated for DPPH activity. 
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4.3. Results and discussion 
In our quest to identify novel sources of antioxidant from uncommonly used 
edible plants, extracts of Garcinia species were investigated for their composition and 
antioxidant properties for the first time, and compared to the well-known related species 
G. mangostana.  
The antioxidant activity of seven Garcinia fruits and the wood of G. kola were 
tested using the DPPH scavenging assay (Table 4.2). The antioxidant activity of Garcinia 
extracts was in the following order G. intermedia (IC50= 60.1  27.3 g/ml), and G. 
mangostana (IC50= 64.3  11.3 g/ml)  G. livingstonei (IC50= 108.4  12.9 g/ml), 
Garcinia hombroniana (IC50= 116.8  66.8 g/ml), G. aristata (IC50= 128.9  13.6 
g/ml), and G. xanthochymus (IC50= 152.7  12.1 g/ml)  G. kola (IC50= 205.1  38.8 
g/ml)  G. spicata (IC50= 185.3  20.9 g/ml) (Table 4.2). The scavenging activities 
displayed by G. intermedia and G. mangostana were significantly higher than the other 
tested Garcinia extracts.  
The total phenolic content (TPC) Garcinia extracts was assessed using the Folin-
Ciocalteau method, and the results are shown in Table 4.2. The TPC decreased in the 
following order G. intermedia (476.9  40.8 GAE per g dry fruit)  G. hombroniana 
(326.9  8.1 GAE per g of dry fruit), G. xanthochymus (283.6  65.3 GAE per g of dry 
fruit), G. mangostana (263.3  6.4 GAE per g of dry fruit), G. kola (248.3  48.7 GAE 
per g dry fruit), G. spicata (237.6   15.6 GAE per g of dry fruit), and G. aristata (237.1 
 6.3 GAE per g of dry fruit)  G. livingstonei (115.5  34.1 GAE per g of dry fruit). 
Garcinia intermedia has the highest amount of TPC compared to other Garcinia extracts. 
Multivariate analysis did not show any correlation between TPC and antioxidant activity  
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(r = -0.39), indicating that compounds other than the seven polyphenols quantified, 
contribute significantly to antioxidant activity.100 However, there was significant 
correlation between the contents of guttiferone A and TPC (r = 0.78). 
This is the first study in which both benzophenones and biflavonoids are 
quantified simultaneously in eight Garcinia species. The amounts of benzophenones and 
biflavonoids were quantified by HPLC-PDA and a good linearity was achieved over the 
concentration range presented, the seven calibration curves exhibited linear regressions of 
at least R20.966. The limits of detection (LOD) and of quantitation (LOQ) were 
determined under the operational conditions of the method (Table 4.1). 
Polyisoprenylated benzophenones were present in the fruits of G. spicata, G. 
xanthochymus, G. intermedia, G. livingstonei, and G. aristata. The amounts in mg/g of 
dry fruit of polyisoprenylated benzophenones and biflavonoid in seven Garcinia species 
are presented in Table 4.3. The content of xanthochymol decreased in the following order 
G. spicata (70.50  1.10 mg/ g dry weight)  G. xanthochymus (65.10  0.03 mg/g dry 
weight)  G. intermedia (2.90  0.20 mg/g dry weight). Previous studies quantifying 
xanthochymol, found 35.60  3.60 mg/g of present in fruits of G. indica.101 The amount 
of guttiferone E decreased in the following order, G. spicata (50.00  2.10 mg/g dry 
weight) and G. xantochymus (48.10  2.60 mg/g dry weight)  G. intermedia (3.50  
0.20 mg/g dry weight). The content of guttiferone A decreased in the following order in 
the fruits; G. intermedia (43.00  0.30 mg/g dry weight)  G. aristata (31.30 0.30 mg/g 
dry weight)  G. livingstonei (11.20 0.50 mg/g dry weight)  G. spicata (4.80  0.07 
mg/g dry weight). High amounts of guttiferone A in Garcinia fruits correlate with high 
levels of DPPH activity (r= -0.79).  
Among the biflavonoids analyzed, fukugetin decreased in the following order:  
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G. xanthochymus (12.90  0.70 mg/g dry weight)  G. spicata (4.90  0.20 mg/g dry 
weight)  G. intermedia (4.60  0.04 mg/g dry weight)  G. livingstonei (2.90  0.10 
mg/g dry weight). The content of volkensiflavone decreased in the following order G. 
hombroniana (12.40  0.20 mg/g dry weight)  G. kola (5.60  0.10 mg/g dry weight)  
G. xanthochymus (1.50  0.01 mg/g dry weight)  G. intermedia (0.90  0.08 mg/g dry 
weight) and G. livingstonei (0.80  0.10 mg/g dry weight). The content of fukugeside 
decreased in the following order G. xanthochymus (9.90  0.60 mg/g dry weight)  G. 
spicata (5.40  0.10 mg/g dry weight)  G. intermedia (3.20  0.20 mg/g dry weight  G. 
livingstonei (1.10  0.06 mg/g dry weight). The content of amentoflavone decreased in 
the following order G. spicata (0.30  0.10 mg/g dry weight)  G. livingstonei (0.20  
0.03 mg/g dry weight)  G. xanthochymus (0.10  0.01 mg/g dry weight). 
Garcinia spicata contained all the seven phytochemical constituents. Four 
biflavonoids were detected in each of the following species: Garcinia livingstonei, G. 
xanthochymus, and G. spicata. Biflavonoids are known for anti-inflammatory and 
analgesic effects.102 Garcinia intermedia showed the presence of xanthochymol and 
gutiferone E, although guttiferone A is the major constituent present in the fruit.  
Garcinia mangostana and G. hombroniana show significant differences from the 
other tested Garcinia species in their phytochemistry (lacking polyisoprenylated 
benzophenones in their fruits), morphology (having hard rinds), and biogeography (both 
native to Southeast Asia). These differences are in agreement with Sweeney, who divides 
the genus Garcinia into two phylogenetic lineages, namely A (containing G. spicata, G. 
kola, G. intermedia, and G. livingstonei) and B (containing G. mangostana and G. 
hombroniana) based on morphology and genetic variation.12 Based on our limited sample 
set, lineage A produces polyprenylated benzophenones, whereas lineage B does not, 
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instead making the related compounds xanthones. However, the phytochemistry of 
additional species in lineages A and B needs to be tested for this hypothesis to be 
confirmed. In addition, the role of environmental factors on Garcinia fruits has not been 
considered in this study. 
In previous studies we have found that guttiferone E displays a higher activity 
than its double-bond isomer xanthochymol against colon cancer.25 In this study the 
separation between the double bond isomers was only achieved on a reversed-phase C18 
column using a long run-time with a mobile phase composed of ammonium acetate 
buffer and acetonitrile. This led to a total run time of 100 min. The selectivity factor α for 
the adjacent bands of the pair of double bond isomers was  = 1.03 for guttiferone E, and 
xanthochymol, but the resolution required isocratic conditions of 49 % A and 51 % B for 
70 min. Separation of the structurally related double-bond isomers, guttiferone E and 
xanthochymol was achieved. The only difference is that guttiferone E has a double bond 
between carbon C-32 and C-33, while xanthochymol has a terminal double bond between 
carbon C-33 and C-34 (Fig. 4.1). Thus the only structural difference is the sp - 2 
hybridization on C-32 and C-34. Separation of closely related olefinic isomers is 
challenging and different stationary phases for separation and improvement of the 
resolution of olefinic isomers of estrogens have previously been evaluated.103 Low 
retention time was achieved for early eluting fukugeside and the biflavonoids. The 
compounds were identified based on retention time and UV absorbance in comparison 
with individual standards. The seven peaks were identified based on the UV data and 
absorbance spectra characteristic of polyisoprenylated benzophenones and biflavonoids. 
The chromatographic method worked for the eight analyzed extracts.  
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Dietary supplements containing G. mangostana are increasingly marketed to 
consumers with claims of potential health beneficial effects; however, these claims need 
to be clinically evaluated.104 The major constituent present in G. mangostana is -
mangostin.93 A recent study has shown that the human plasma antioxidant capacity 
increases after one oral dose of mangosteen product. The bioavailablity of -mangostin 
reaches its maximum concentration in plasma (Cmax) 3.12 1.47 ng /ml at tmax of 1 h after 
consumption of mangosteen dietary product.105 
Previous studies have shown that G. mangostana is a rich source of xanthones, 
anthocyanins, and oligomeric proanthocyanidins.92 New xanthone compounds have been 
isolated from G. mangostana.106 Polyisoprenylated benzophenones were detected in the 
stem bark and heartwood of G. mangostana. 107,108 Studies in vitro have shown that the 
isolated compounds from G. mangostana display antioxidant, anti-inflammatory, 
antimicrobial, and cytotoxic activity.104 A crude methanolic extract showed 
antiproliferative effects 104 and recent studies suggest that -mangostin is a potential 
cancer chemopreventive compound.106 Toxicity studies in mice have shown that orally 
administered G. mangostana extract showed LD50 = 9.37 g/kg weight.109  
Garcinia species may be important in the prevention and/or treatment of cancer.15 
For example, G. xanthochymus has shown activity against colon cancer cells.25 There is 
evidence that suggests that polyisoprenylated benzophenones induce apoptosis and arrest 
the cell cycle early in G1 phase, and prevent the transcription and translation of important 
cell-cycle regulators involved in cell progression in cancerous cells.38 Thus they arrest the 
cell cycle and interrupt cell division and inhibit the growth of cancer cells, up-regulating 
mediators in the ER stress pathway.38 The mechanism of action and cellular pathways 
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through which the benzophenones exert chemopreventive effects is still under 
investigation. 
Conclusions 
The fruit of G. intermedia has significantly higher antioxidant capacity and total 
phenolic content than the “superfruit” G. mangostana. Therefore, a new source of 
antioxidants has been identified, which might be of great potential to human health. 
However, further biological studies on the safety and efficacy of the fruit are warranted. 
The fruits of G. spicata and G. xanthochymus contain the highest amounts of guttiferone 
E and xanthochymol. These polyisoprenylated benzophenones are reported to have 
chemopreventive effects against the early stages of carcinogenesis and thus have health 
beneficial effects. The HPLC-PDA method used for identification and quantification of 
polyisoprenylated benzophenones and biflavonoids was sensitive, reproducible and fully 
validated.
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Figure 4.1. Polyisoprenylated benzophenones and biflavonoids quantified in the fruits of seven Garcinia species in this study. 
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5 
G. spicata 
Mixture of standards 
2 3 4 6
7
1 
G. xanthochymus 
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Figure 4.2. Chromatograms of eight Garcinia extracts analyzed at 280 nm. (1) Fukugeside (2) Fukugetin (3) 
Amentoflavone (4) Volkensiflavone (5) Guttiferone A (6) Xanthochymol (7) Guttiferone E. 
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  Linear regression data         Analytes 
tR, (min) UV data (, nm) Regressive equation Test range (g ml-1) R2 LOD (ng ml-1) LOQ (ng ml-1) 
Fukugeside (1) 6 256, 329 y =107x+355580 24.9-1.3x105  1.000 720 2397 
Fukugetin (2) 17 288, 327 y =2x107x-106 19.6-1.0x105 0.999 109 363 
Amentoflavone (3) 20 212, 292 y =2x107x +458366 12.6-6.5x103 0.999 260  867 
Volkensiflavone (4) 28 212, 292, 328 y =2x107x+456891 2.6-2.7x103 0.998 337 1124 
Guttiferone A (5) 53 229, 280 y =107x+870060 14.0-7.2x103 0.998 330 1100 
Xanthochymol (6) 90 233, 279 y =3x106x+340315 6.5-3.4x103 0.966 707 2357 
Guttiferone E (7) 93 229, 279 y=3x107x+108058 6.6-2.2x103 0.998 482 1607 
 Table 4.1. Concentration range of analyzed standards, equations of the calibration curves and linear regression coefficients. 
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Table 4.2. DPPH activitya and total phenolic contenta (TPC) in eight Garcinia species
Sample DPPH (g/ml) TPC (GAE/g) 
G. mangostana 64.311.3a 263.36.4a 
G. hombroniana 116.866.8ab 326.98.1a 
G. livingstonei 108.412.9ab 115.534.1b 
G. xanthochymus 152.712.1ab 283.665.3a 
G. intermedia 60.127.3a 476.8740.8c 
G. aristata 128.913.6ab 237.16.3a 
G. spicata 185.320.9c 237.615.6a 
G. kola 205.138.8b 248.348.7a 
a Values are expressed as means  SD of three replicate analysis.  
Means in the same column with different letters are not significantly different (p 0.05) 
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Table 4.3. Benzophenones and biflavonoids (mg/gram of dry weight) contents of eight Garcinia fruits and G.kola wood species.a 
 
 Fukugeside (1) Fukugetin (2) Amentoflavone (3) Volkensiflavone (4) Guttiferone A (5) Xanthochymol (6) Guttiferone E (7) 
G. spicata 5.40±0.10a 4.90±0.20a 0.30±0.10a 0.40±0.01a 4.80±0.07a 70.50±1.10a 50.00±2.10a 
G. xanthochymus 9.90±0.60b 12.90±0.70b 0.10±0.01b 1.50±0.01b nd 65.10±0.03b 48.10±2.60a 
G. intermedia 3.20±0.20c 4.60±0.04c nd 0.90±0.08c 43.00±0.30b 2.90±0.20c 3.50±0.20b 
G. livingstonei 1.10±0.06d 2.90±0.10d 0.20±0.03a 0.80±0.10c 11.20±0.50c nd nd 
G. aristata nd nd nd nd 31.30±0.30d nd nd 
G. hombroniana nd nd nd 12.40±0.20d nd nd nd 
G. kola nd nd nd 5.60±0.10e nd nd nd 
G. mangostana nd nd nd nd nd nd nd 
a Values are expressed as means  SD of three replicate analysis. Means in the same column with different letters are significantly 
different (p 0.05) 
nd= not detected 
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Chapter 5 
Conclusions 
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By high performance liquid chromatography photo-diode array (HPLC-PDA) we 
have quantified the amounts of three major bioactive benzophenones, guttiferone A, 
guttiferone E, and xanthochymol, in seven species of Garcinia fruits, including the 
“superfruit” Garcinia mangostana. In addition, four biflavonoids were quantified: 
amentoflavone, fukugeside, fukugetin, and volkensiflavone. The quantitative HPLC 
method was validated with respect to linearity, accuracy, recovery, and precision. The 
amounts of benzophenones and biflavonoids were quantified by HPLC-PDA and a good 
linearity was achieved over the concentration range presented, the seven calibration 
curves exhibited linear regressions of at least R2  0.966. The limit of detection LOD was 
determined. The antioxidant activity of the Garcinia fruits and the wood of G. kola were 
tested. The highest antioxidant activity was displayed by G. intermedia (IC50= 60.1  
27.3 g/ml) and G. mangostana (IC50= 64.3  27.3 g/ml). In comparison, the wood of 
G. kola showed the lowest antioxidant activity (IC50=205.1  38.8 g/ml) in this study.  
The total phenolic content was 476.9  40.8 GAE per gram dry fruit for G. 
intermedia. This value was followed by followed by G. hombroniana which showed a 
TPC of 326.9  8.1 GAE per gram of dry fruit. “The superfruit” G. mangostana had a 
TPC of 263.3  6.4 GAE per gram of dry fruit. G. kola had 248.3  48.7 GAE per gram 
of dry fruit. We have found that the tropical fruits of G. intermedia, G. mangostana, and 
G. hombroniana display high antioxidant activity and contain a high level of total 
phenolic compounds. The highest amounts of guttiferone E and xanthochymol were 
found in both G. spicata and G. xanthochymol. Highest amount of guttiferone E was 
found in G. spicata (50.0  2.1 mg/g dry weight). In this study xanthochymol was present 
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in three of the analyzed fruits and quantified. The highest amount was detected in G. 
spicata (70.5  1.1 mg/g dry weight). Guttiferone A was found at the highest levels in G. 
intermedia (43.0  0.3 mg/g dry weight), followed by G. aristata (31.3  0.3 mg/g dry 
weight), while the lowest levels of guttiferone A were observed in G. livingstonei (11.2  
0.5 mg/g dry weight).  
We have found that the fruits of G. intermedia (IC50= 60.1  27.3 g/ml) have 
higher antioxidant capacity than G. mangostana (IC50= 64.3  11.3 g/ml) and thus we 
have identified a new sustainable source of compounds with higher antioxidant activity 
than the “superfruit” mangosteen.  
 Overall the chemical profile and the content of polyisoprenylated benzophenones 
are different among species of Garcinia fruits. The fruits with a hard pericarp do not 
show the presence of polyisoprenylated benzophenones. Both the fruit extracts of G. 
mangostana and G. intermedia, displayed high content of total phenolic content and high 
antioxidant capacity. Noteworthy is the fact that the Central American species G. 
intermedia showed higher antioxidant activity than the “superfruit” G. mangostana. 
  In the fruits of Garcinia intermedia the following known compounds were 
identified: guttiferone A, guttiferone E, isoxanthochymol, xanthochymol, aristophenone, 
maclurin, fukugetin, and volkensiflavone. One new benzophenone isomer of m/z 618 was 
isolated and tentatively identified using 1D and 2D NMR experiments.  
The antioxidant activity for guttiferone A (IC50= 46 µM) is comparable to gallic 
acid (IC50= 35 µM). Guttiferone A, a major constituent in G. intermedia, showed 
antiproliferative effects (9 µg/ml). Further it did not only enhance the effects of the 
chemopreventive agent sulindac sulfide against colon cancer HT-29 cells but also showed 
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strong synergistic activity in combination with the chemopreventive agent. Guttiferone A 
is a possible new lead compound for a potentially new chemopreventive agent of colon 
cancer. 
Many new polyisoprenylated benzophenones with a bicyclo[3.3.1]-nonane-2,4,9-
trione core structure have been isolated from plants in the Clusiaceae family, and their 
potent biological properties have been the subject of several studies. The cellular target 
through which guttiferone A exerts antiproliferative effects, and interrupts the cell cycle 
of cancer cells, needs to be investigated. The target of guttiferone A in colon caner cells 
needs to be identified, in order to be able to produce effective benzophenone analogues 
for chemoprevention. It is possible that guttiferone A affects the inflammatory mediation 
during the initiation of carcinogenesis, having an effect on the inducible enzymes iNOS 
and COX-2. This may be the mechanism of action through which polyisoprenylated 
benzophenones exert their antiproliferative effects in vitro. Evidence presented by 
independent investigators suggests that polyisoprenylated benzophenones affect the 
mediators in the Akt/mTOR stress pathway, although the specific target remains to be 
discovered. In addition, benzophenones isolated from plants display high antioxidant 
capacity and protect cells from oxidative stress, and the formation of ROS involved 
during the inflammatory process. 
There is clinical evidence suggesting that breast cancer can be prevented in 
women with relative high risk of developing the disease, by means of pharmacological 
treatment and chemoprevention.110 This shows that pharmacologic treatment, with the 
purpose of arresting and/or reversing the process of carcinogenesis, is a potential 
alternative for future efficient prevention of cancer. 111 During the early stages of colon 
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carcinogenesis there is over-expression of the cyclooxygenase-2 (COX-2). The mediators 
in the inflammatory response are up regulated in the initial stages of carcinogenesis in 
colon cancer cells. It is possible that guttiferone A also suppresses the inflammatory 
response during the initiation of carcinogenesis. 
New approaches to control the disease are critically needed, and the prevention of 
the initiation of cancerogenesis is essential for the reduction in the incidence of the 
disease. New classes of compounds with chemopreventive effects, with the potential of 
being developed into lead compounds to prevent cancer are needed for future efficacious 
pharmacological treatment. Moreover, the discovery of a putative target might lead to 
more effective treatments against cancer, and possibly find an alternative approach 
through which cancer can be prevented.  
Fruits of Garcinia plants are a rich dietary source of phenolic compounds. These 
findings suggest that fruits of G. intermedia which are rich in guttiferone A, might 
prevent colon cancer, and that the consumption of the fruit might have potential 
chemopreventive effects. Garcinia fruits are a rich dietary source of new phenolic 
compounds, particularly polyisoprenylated benzophenones high in antioxidant capacity. 
The polyisoprenylated benzophenones might prevent the damaging effects of free 
radicals involved in the etiology of atherosclerosis and other inflammatory processes. In 
addition, these compounds have shown antiproliferative effects. The phenolic compounds 
in Garcinia fruits have antioxidant activity and antiproliferative effects and may possibly 
prevent certain types of cancer. 
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